10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended October 31, 2021

or

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from ___________ to ___________

Commission file number 001-38175

ASPEN GROUP, INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware	27-1933597
State or Other Jurisdiction of Incorporation or Organization	I.R.S. Employer Identification No.
276 Fifth Avenue, Suite 505, New York, New York	10001
Address of Principal Executive Offices	Zip Code

(646) 448-5144

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001	ASPU	The Nasdaq Stock Market (The Nasdaq Global Market)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes þ     No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes þ    No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨	Accelerated filer ¨
Non-accelerated filer ☑	Smaller reporting company ☑
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes ☐    No þ 

Class	Outstanding as of December 10, 2021
Common Stock, $0.001 par value per share	25,034,375 shares

TABLE OF CONTENTS

		Page Number
	PART I – FINANCIAL INFORMATION
Item 1.	Financial Statements.	1
	Consolidated Balance Sheets	1
	Consolidated Statements of Operations (Unaudited)	3
	Consolidated Statements of Changes in Stockholders’ Equity (Unaudited)	4
	Consolidated Statements of Cash Flows (Unaudited)	5
	Condensed Notes to Consolidated Financial Statements (Unaudited)	8
	Note 1. Nature of Operations	8
	Note 2. Significant Accounting Policies	9
	Note 3. Property and Equipment	11
	Note 4. Courseware and Accreditation	11
	Note 5. Secured Note and Accounts Receivable	12
	Note 6. Long-term Debt	12
	Note 7. Stockholders' Equity	13
	Note 8. Revenue	17
	Note 9. Leases	18
	Note 10. Income Taxes	20
	Note 11. Commitments and Contingencies	20
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	23
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	38
Item 4.	Controls and Procedures.	38
	PART II – OTHER INFORMATION
Item 1.	Legal Proceedings.	39
Item 1A.	Risk Factors.	39
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	39
Item 3.	Defaults Upon Senior Securities.	39
Item 4.	Mine Safety Disclosures.	39
Item 5.	Other Information.	39
Item 6.	Exhibits.	39
	SIGNATURES	41

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

	October 31, 2021		April 30, 2021
	(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$	10,985,131	$	12,472,082
Restricted cash	1,433,397		1,193,997
Accounts receivable, net of allowance of $3,345,182 and $3,289,816, respectively	21,309,982		16,724,744
Prepaid expenses	1,577,516		1,077,831
Other current assets	20,631		68,529
Total current assets	35,326,657		31,537,183
Property and equipment:
Computer equipment and hardware	1,402,006		956,463
Furniture and fixtures	1,976,342		1,705,101
Leasehold improvements	7,057,859		5,729,324
Instructional equipment	608,894		421,039
Software	9,386,352		8,488,635
Construction in progress	900		247,767
	20,432,353		17,548,329
Less: accumulated depreciation and amortization	(6,672,208)		(4,892,987)
Total property and equipment, net	13,760,145		12,655,342
Goodwill	5,011,432		5,011,432
Intangible assets, net	7,907,503		7,908,360
Courseware, net	299,914		187,296
Accounts receivable, net of allowance of $— and $625,963, respectively	—		45,329
Long-term contractual accounts receivable	12,663,815		10,249,833
Deferred financing costs	117,857		18,056
Operating lease right of use assets, net	13,510,656		12,714,863
Deposits and other assets	515,569		479,212
Total assets	$	89,113,548	$	80,806,906

(Continued)

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.

1

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (CONTINUED)

	October 31, 2021		April 30, 2021
	(Unaudited)
Liabilities and Stockholders’ Equity
Liabilities:
Current liabilities:
Accounts payable	$	2,102,624	$	1,466,488
Accrued expenses	1,772,808		2,040,896
Deferred revenue	10,191,241		6,825,014
Due to students	3,219,643		2,747,484
Operating lease obligations, current portion	2,145,431		2,029,821
Other current liabilities	96,003		307,921
Total current liabilities	19,527,750		15,417,624
Long-term debt	5,000,000		—
Operating lease obligations, less current portion	17,732,483		16,298,808
Total liabilities	42,260,233		31,716,432
Commitments and contingencies – see Note 11
Stockholders’ equity:
Preferred stock, $0.001 par value; 1,000,000 shares authorized,
0 issued and 0 outstanding at October 31, 2021 and April 30, 2021	—		—
Common stock, $0.001 par value; 40,000,000 shares authorized,
25,148,194 issued and 24,992,708 outstanding at October 31, 2021
25,066,297 issued and 24,910,811 outstanding at April 30, 2021	25,149		25,067
Additional paid-in capital	110,526,729		109,040,824
Treasury stock (155,486 at both October 31, 2021 and April 30, 2021)	(1,817,414)		(1,817,414)
Accumulated deficit	(61,881,149)		(58,158,003)
Total stockholders’ equity	46,853,315		49,090,474
Total liabilities and stockholders’ equity	$	89,113,548	$	80,806,906

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.

2

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended October 31,				Six Months Ended October 31,
	2021		2020		2021		2020
Revenue	$	18,940,211	$	16,971,045	$	38,371,206	$	32,136,607
Operating expenses:
Cost of revenue (exclusive of depreciation and amortization shown separately below)	8,789,201		7,324,780		17,382,769		13,172,303
General and administrative	11,641,312		11,285,155		22,587,789		20,078,911
Bad debt expense	350,000		632,000		700,000		1,032,000
Depreciation and amortization	817,234		526,357		1,596,643		1,016,981
Total operating expenses	21,597,747		19,768,292		42,267,201		35,300,195
Operating loss	(2,657,536)		(2,797,247)		(3,895,995)		(3,163,588)
Other income (expense):
Interest expense	(139,502)		(1,529,668)		(173,041)		(1,985,125)
Other (expense) income, net	(49,320)		(7,080)		502,800		(130,378)
Total other (expense) income, net	(188,822)		(1,536,748)		329,759		(2,115,503)
Loss before income taxes	(2,846,358)		(4,333,995)		(3,566,236)		(5,279,091)
Income tax expense	5,900		36,530		156,910		34,630
Net loss	$	(2,852,258)	$	(4,370,525)	$	(3,723,146)	$	(5,313,721)
Net loss per share - basic and diluted	$	(0.11)	$	(0.19)	$	(0.15)	$	(0.23)
Weighted average number of common stock outstanding - basic and diluted	24,957,046		22,791,503		24,935,793		22,763,235

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.

3

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

Three Months Ended October 31, 2021 and 2020

(Unaudited)

	Common Stock			Additional Paid-In Capital		Treasury Stock		Accumulated Deficit		Total Stockholders’ Equity
	Shares	Amount
Balance at July 31, 2021	25,087,051	$	25,088	$	109,617,521	$	(1,817,414)	$	(59,028,891)	$	48,796,304
Stock-based compensation	—	—		722,158		—		—		722,158
Common stock issued for stock options exercised for cash	11,655	12		33,474		—		—		33,486
Common stock issued for cashless stock options exercised	30,156	30		(30)		—		—		—
Common stock issued for vested restricted stock units	19,332	19		(19)		—		—		—
Amortization of warrant based cost	—	—		16,125		—		—		16,125
Warrants issued for deferred financing costs related to Credit Facility	—	—		137,500		—		—		137,500
Net loss	—	—		—		—		(2,852,258)		(2,852,258)
Balance at October 31, 2021	25,148,194	$	25,149	$	110,526,729	$	(1,817,414)	$	(61,881,149)	$	46,853,315
	Common Stock			Additional Paid-In Capital		Treasury Stock		Accumulated Deficit		Total Stockholders’ Equity
	Shares	Amount
Balance at July 31, 2020	22,377,744	$	22,378	$	92,378,584	$	(70,000)	$	(48,652,226)	$	43,678,736
Stock-based compensation	—	—		1,831,548		—		—		1,831,548
Common stock issued for stock options exercised for cash	502,412	502		944,830		—		—		945,332
Common stock issued for cashless stock options exercised	22,339	22		(22)		—		—		—
Common stock issued for conversion of Convertible Notes	1,398,602	1,399		9,998,601		—		—		10,000,000
Common stock issued for vested restricted stock units	132,109	132		(132)		—		—		—
Amortization of warrant based cost	—	—		9,125		—		—		9,125
Cancellation of Treasury Stock	(16,667)	(17)		(69,983)		70,000		—		—
Net loss	—	—		—		—		(4,370,525)		(4,370,525)
Balance at October 31, 2020	24,416,539	$	24,416	$	105,092,551	$	—	$	(53,022,751)	$	52,094,216

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.

4

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (CONTINUED)

Six Months Ended October 31, 2021 and 2020

(Unaudited)

	Common Stock			Additional Paid-In Capital		Treasury Stock		Accumulated Deficit		Total Stockholders’ Equity
	Shares	Amount
Balance at April 30, 2021	25,066,297	$	25,067	$	109,040,824	$	(1,817,414)	$	(58,158,003)	$	49,090,474
Stock-based compensation	—	—		1,264,870		—		—		1,264,870
Common stock issued for stock options exercised for cash	16,752	17		56,017		—		—		56,034
Common stock issued for cashless stock options exercised	30,156	30		(30)		—		—		—
Common stock issued for vested restricted stock units	34,989	35		(35)		—		—		—
Amortization of warrant based cost	—	—		27,583		—		—		27,583
Warrants issued for deferred financing costs related to Credit Facility	—	—		137,500		—		—		137,500
Net loss	—	—		—		—		(3,723,146)		(3,723,146)
Balance at October 31, 2021	25,148,194	$	25,149	$	110,526,729	$	(1,817,414)	$	(61,881,149)	$	46,853,315
	Common Stock			Additional Paid-In Capital		Treasury Stock		Accumulated Deficit		Total Stockholders’ Equity
	Shares	Amount
Balance at April 30, 2020	21,770,520	$	21,771	$	89,505,216	$	(70,000)	$	(47,709,030)	$	41,747,957
Stock-based compensation	—	—		2,318,658		—		—		2,318,658
Common stock issued for stock options exercised for cash	917,587	918		2,214,397		—		—		2,215,315
Common stock issued for cashless stock options exercised	22,339	22		(22)		—		—		—
Common stock issued for conversion of Convertible Notes	1,398,602	1,399		9,998,601		—		—		10,000,000
Common stock issued for vested restricted stock units	132,109	132		(132)		—		—		—
Common stock issued for warrants exercised for cash	192,049	191		1,081,600		—		—		1,081,791
Modification charge for warrants exercised	—	—		25,966		—		—		25,966
Amortization of warrant based cost	—	—		18,250		—		—		18,250
Cancellation of Treasury Stock	(16,667)	(17)		(69,983)		70,000		—		—
Net loss	—	—		—		—		(5,313,721)		(5,313,721)
Balance at October 31, 2020	24,416,539	$	24,416	$	105,092,551	$	—	$	(53,022,751)	$	52,094,216

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.

5

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Six Months Ended October 31,
	2021		2020
Cash flows from operating activities:
Net loss	$	(3,723,146)	$	(5,313,721)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense	700,000		1,032,000
Depreciation and amortization	1,596,643		1,016,981
Stock-based compensation	1,264,870		2,318,658
Amortization of warrant based cost	27,583		18,250
Amortization of debt discounts	—		1,550,854
Amortization of debt issue costs	18,056		147,695
Amortization of deferred financing costs	19,643		—
Modification charge for warrants exercised	—		25,966
Loss on asset disposition	36,442		—
Lease benefit	(63,099)		—
Tenant improvement allowances received from landlords	816,591		—
Changes in operating assets and liabilities:
Accounts receivable	(7,699,220)		(8,246,180)
Prepaid expenses	(520,685)		(654,268)
Other receivables	—		23,097
Other current assets	47,901		(273,767)
Accounts receivable, other	45,329		—
Deposits and other assets	(15,357)		(171,303)
Accounts payable	636,136		838,421
Accrued expenses	(268,088)		1,282,983
Due to students	472,159		(301,619)
Deferred revenue	3,366,227		4,915,504
Other current liabilities	(211,918)		(286,372)
Net cash used in operating activities	(3,453,933)		(2,076,821)
Cash flows from investing activities:
Purchases of courseware and accreditation	(149,751)		(11,375)
Purchases of property and equipment	(2,699,901)		(2,233,348)
Net cash used in investing activities	(2,849,652)		(2,244,723)
Cash flows from financing activities:
Borrowings under the Credit Facility	5,000,000		—
Proceeds from stock options exercised	56,034		2,215,315
Proceeds from warrants exercised	—		1,081,792
Net cash provided by financing activities	5,056,034		3,297,107

(Continued)

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.

6

ASPEN GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(Unaudited)

	Six Months Ended October 31,
	2021		2020
Net decrease in cash, cash equivalents and restricted cash	$	(1,247,551)	$	(1,024,437)
Cash, cash equivalents and restricted cash at beginning of period	13,666,079		17,906,765
Cash, cash equivalents and restricted cash at end of period	$	12,418,528	$	16,882,328
Supplemental disclosure cash flow information:
Cash paid for interest	$	98,904	$	285,749
Cash paid for income taxes	$	157,552	$	38,608
Supplemental disclosure of non-cash investing and financing activities:
Common stock issued for conversion of Convertible Notes	$	—	$	10,000,000
Warrants issued as part of Credit Facility	$	137,500	$	—

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the accompanying consolidated balance sheet to the total amounts shown in the accompanying unaudited consolidated statements of cash flows:

	October 31, 2021		April 30, 2021
Cash and cash equivalents	$	10,985,131	$	12,472,082
Restricted cash	1,433,397		1,193,997
Total cash, cash equivalents and restricted cash	$	12,418,528	$	13,666,079

The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.

7

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2021

(Unaudited)

Note 1. Nature of Operations

Overview

Aspen Group, Inc. ("AGI") is an education technology holding company. AGI has two subsidiaries, Aspen University Inc. ("Aspen University"), organized in 1987, and United States University Inc. ("United States University" or "USU").

All references to the “Company”, “AGI”, “Aspen Group”, “we”, “our” and “us” refer to Aspen Group, Inc., unless the context otherwise indicates.

AGI leverages its education technology infrastructure and expertise to allow its two universities, Aspen University and United States University, to deliver on the vision of making college affordable again. Because we believe higher education should be a catalyst to our students’ long-term economic success, we exert financial prudence by offering affordable tuition that is one of the greatest values in higher education.  AGI’s primary focus relative to future growth is to target the high growth nursing profession.

Since 1993, Aspen University has been nationally accredited by the Distance Education Accrediting Council (“DEAC”), an institutional accrediting agency recognized by the United States Department of Education (the “DOE”), through January 2024.

Since 2009, USU has been institutionally accredited by WASC Senior College and University Commission. (“WSCUC”).

Both universities are qualified to participate under the Higher Education Act of 1965, as amended (HEA) and the Federal student financial assistance programs (Title IV, HEA programs). USU has a provisional certification resulting from the ownership change of control in connection with the acquisition by AGI on December 1, 2017.

COVID-19 Update

Nursing students represented 87% or 12,442 of the Company’s total student body of 14,318 students at the end of the second quarter of fiscal 2022. Of the 12,442 nursing students, 2,500 are BSN Pre-Licensure students located across our four metro locations (Phoenix, Austin, Tampa and Nashville). The remaining 9,942 nursing students are licensed registered nurses (RNs) studying to earn an advanced degree (RN to BSN, MSN, MSN-FNP or DNP degree programs). Therefore, these 9,942 post-licensure nursing students represent 69% of the Company’s total student body and are the population of AGI students primarily affected by the COVID-19 pandemic.

Starting in the second half of June 2021 and continuing through October 2021, the Company saw lower course starts than seasonally expected among our RN student body. For example, at Aspen University, course starts among RNs from June through October increased by approximately 3% year-over-year. By comparison, over the previous two full fiscal years (Fiscal Year 2021 and Fiscal Year 2020), course starts among RNs at Aspen University increased by an average of approximately 10% year-over-year.

In terms of new student enrollments, the Company saw enrollment growth on a quarterly sequential basis in all BSN Pre-Licensure metros as these prospective students continue to communicate a strong desire to enter the nursing profession. However, aggregate enrollments among RNs at both Aspen University and United States University were relatively flat on a quarterly sequential basis.

We cannot be certain what impact the Delta variant and other variants will have on the Company’s results as we progress through the second half of fiscal 2022.

Basis of Presentation

Interim Financial Statements

8

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2021

(Unaudited)

The interim consolidated financial statements included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring adjustments) necessary to present fairly our results of operations for the three and six months ended October 31, 2021 and 2020, our cash flows for the six months ended October 31, 2021 and 2020, and our financial position as of October 31, 2021 have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year.

Certain information and disclosures normally included in the notes to the annual consolidated financial statements have been condensed or omitted from these interim consolidated financial statements. Accordingly, these interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended April 30, 2021 as filed with the SEC on July 13, 2021. The April 30, 2021 consolidated balance sheet is derived from those statements.

Note 2. Significant Accounting Policies

Basis of Presentation and Consolidation

The Company prepares its consolidated financial statements in accordance with U.S. generally accepted accounting principles ("GAAP").

The consolidated financial statements include the accounts of AGI and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

A full listing of our significant accounting policies is described in Note 2 “Summary of Significant Accounting Policies” of our Annual Report on Form 10-K for the fiscal year ended April 30, 2021 as filed with the SEC on July 13, 2021.

Accounting Estimates

Management of the Company is required to make certain estimates, judgments and assumptions during the preparation of its consolidated financial statements in accordance with GAAP. These estimates, judgments and assumptions impact the reported amounts of assets, liabilities, revenue and expenses and the related disclosure of contingent assets and liabilities. Actual results could differ from those estimates.

Significant estimates in the accompanying consolidated financial statements include the allowance for doubtful accounts and other receivables, the valuation of lease liabilities and the carrying value of the related right-of-use ("ROU") assets, depreciable lives of property and equipment, amortization periods and valuation of courseware, intangibles and software development costs, valuation of goodwill, valuation of loss contingencies, valuation of stock-based compensation and the valuation allowance on deferred tax assets.

Cash, Cash Equivalents, and Restricted Cash

For the purposes of the consolidated statements of cash flows, the Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.

Restricted cash as of October 31, 2021 of $1,433,397 consists of $1,173,525 which is collateral for letters of credit for the Aspen University and USU facility operating leases, $9,872 which is collateral for a letter of credit for USU required to be posted based on the level of Title IV funding in connection with USU's most recent Compliance Audit, and a $250,000 compensating balance under a secured credit line.

Restricted cash as of April 30, 2021 of $1,193,997 consisted of $934,125 which is collateral for letters of credit for the Aspen University and USU facility operating leases, $9,872 which is collateral for a letter of credit for USU required to be posted based on the level of Title IV funding in connection with USU's most recent Compliance Audit, and a $250,000 compensating balance under a secured credit line.

9

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2021

(Unaudited)

Concentration of Credit Risk

The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits of $250,000 per financial institution. The Company has not experienced any losses in such accounts from inception through October 31, 2021. As of October 31, 2021 and April 30, 2021, the Company maintained deposits exceeding federally insured limits by approximately $11,765,690 and $13,005,537, respectively, held in two separate institutions.

Revenue Recognition and Deferred Revenue

The Company follows Accounting Standards Codification 606 (ASC 606). ASC 606 is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASC also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer purchase orders, including significant judgments.

Revenue consists primarily of tuition and course fees derived from courses taught by the Company online and in-person as well as from related educational resources and services that the Company provides to its students. Under ASC 606, tuition and course fee revenue is recognized pro-rata over the applicable period of instruction and are not considered separate performance obligations.  Non-tuition related revenue and fees are recognized as services are provided or when the goods are received by the student. (See Note 8) Students may receive discounts, scholarships, or refunds, which gives rise to variable consideration. The amounts of discounts or scholarships are applied to individual student accounts when such amounts are awarded. Therefore, the tuition is reduced directly by these discounts or scholarships from the amount of the standard tuition rate charged.

Deferred revenue represents the amount of tuition, fees, and other student payments received in excess of the portion recognized as revenue and it is included in current liabilities in the accompanying consolidated balance sheets. Other revenue may be recognized as sales occur or services are performed.

Net Loss Per Share

Net loss per share is based on the weighted average number of shares of common stock outstanding during each period. Options to purchase 992,050 and 1,214,473 shares of common stock, 899,103 and 549,972 restricted stock units ("RSUs"), warrants to purchase 449,174 and 374,174 shares of common stock, and unvested restricted stock of 8,224 and 8,224 were outstanding at October 31, 2021 and April 30, 2021, respectively.

All shares mentioned above were not included in the computation of diluted net loss per share because the effects would have been anti-dilutive. The options, warrants, RSUs and unvested restricted stock are considered to be common stock equivalents and are only included in the calculation of diluted earnings per share of common stock when their effect is dilutive.

Segment Information

The Company operates in one reportable segment as a single educational delivery operation using a core infrastructure that serves the curriculum and educational delivery needs of its online and campus students regardless of geography. The Company's chief operating decision makers, its Chief Executive Officer, Chief Operating Officer and Chief Academic Officer, manage the Company's operations as a whole.

Recent Accounting Pronouncement Not Yet Adopted

ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which significantly changes how entities will measure credit losses for most financial assets, including accounts receivable. ASU No. 2016-13 will replace today’s “incurred loss” approach with an “expected loss” model, under which companies will recognize allowances based on expected rather than incurred losses. On November 15, 2019, the FASB delayed the effective date of Topic 326 for certain small public companies and other private companies until fiscal years

10

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2021

(Unaudited)

beginning after December 15, 2022 for SEC filers that are eligible to be smaller reporting companies under the SEC’s definition, as well as private companies and not-for-profit entities. The Company is currently evaluating the new guidance and has not yet determined whether the adoption of the new standard will have a material impact on its consolidated financial statements or the method of adoption.

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year presentation.

The Company has concluded that based on industry practices, the preferred presentation for cash received in advance for unearned tuition and stipends should be reclassified from "restricted cash" to "cash and cash equivalents." The cash balance of $3,958,793 for funds held for students for unbilled educational services that were received from Title IV and non-Title IV programs at April 30, 2021, which was previously included in "restricted cash" in the accompanying consolidated balance sheet, was reclassified to "cash and cash equivalents" to align with the current year presentation. There is no impact to total current assets included in accompanying consolidated balance sheet at April 30, 2021. The restricted cash balance at April 30, 2021, now includes letters of credit and a compensating balance under a secured credit line of $1,193,997.

Note 3. Property and Equipment

As property and equipment reach the end of their useful lives, the fully expired assets are written off against the associated accumulated depreciation and amortization.

When assets are disposed of before reaching the end of their useful lives both the recorded cost of the fixed asset and the corresponding amount of accumulated depreciation is reversed. Any remaining difference between the two is recognized as either other income or expense.

Software consisted of the following:

	October 31, 2021		April 30, 2021
Software	$	9,386,352	$	8,488,635
Accumulated amortization	(4,284,129)		(3,444,325)
Software, net	$	5,102,223	$	5,044,310

Depreciation and amortization expense for property and equipment and software is summarized below:

	Three Months Ended October 31,				Six Months Ended October 31,
	2021		2020		2021		2020
Depreciation and amortization expense:
Property and equipment, excluding software	$	367,475	$	164,204	$	718,848	$	327,774
Software	$	428,143	$	346,653	$	839,804	$	661,760

Note 4. Courseware and Accreditation

As courseware and accreditation reach the end of their useful life, they are written off against the accumulated amortization. There was no expense impact for such write-offs for the three and six months ended October 31, 2021 and 2020.

11

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2021

(Unaudited)

Courseware and accreditation consisted of the following:

	October 31, 2021		April 30, 2021
Courseware	$	557,973	$	408,222
Accreditation	59,350		59,350
	617,323		467,572
Accumulated amortization	(317,409)		(280,276)
Courseware and accreditation, net	$	299,914	$	187,296

Amortization expense for courseware and accreditation is summarized below:

	Three Months Ended October 31,				Six Months Ended October 31,
	2021		2020		2021		2020
Amortization expense	$	21,185	$	10,516	$	37,133	$	22,463

Amortization expense is included in "Depreciation and amortization" in the unaudited consolidated statements of operations.

Note 5. Secured Note and Accounts Receivable

On March 30, 2008 and December 1, 2008, Aspen University sold courseware pursuant to marketing agreements to Higher Education Management Group, Inc. (“HEMG”), which was then a related party and principal stockholder of the Company. As discussed in Note 11, the Company and Aspen University sued HEMG seeking to recover sums due under the agreements. Ultimately, the Company and Aspen University obtained a favorable default judgment, and as a result received a distribution from the bankruptcy trustee court of $498,120, which is included in "other (expense) income, net" in the accompanying unaudited consolidated statements of operations for the six months ended October 31, 2021. Due to the bankruptcy of HEMG, the Company also wrote off a net receivable of $45,329 in the same period.

Note 6. Long-term Debt

Credit Facility

On November 5, 2018, the Company entered into a loan agreement (the “Credit Facility Agreement”) with the Leon and Toby Cooperman Family Foundation (the “Foundation”). The Credit Facility Agreement provided for a $5,000,000 revolving credit facility (the “Credit Facility”) evidenced by a revolving promissory note (the “Revolving Note”). Borrowings under the Credit Facility Agreement bear interest at 12% per annum. Interest payments are due monthly through the term of the Credit Facility.

On August 31, 2021, the Company extended the Credit Facility Agreement with the Foundation by one year from November 4, 2021 to November 4, 2022. In conjunction with the extension of the Facility, the Company drew down $5,000,000 of funds from the Facility at 12% interest per annum due November 4, 2022.

Additionally, on August 31, 2021, the Company issued to the Foundation warrants, as an extension fee, to purchase 50,000 shares of the Company’s common stock exercisable for five years from the date of issuance at the exercise price of $5.89 per share. The fair value of the warrants is $137,500 and is being amortized over the 14-month line of credit period. The fair value of the warrants are treated as deferred financing costs in the accompanying consolidated balance sheets at October 31, 2021 to be amortized over the term of the Credit Facility. Total unamortized costs at October 31, 2021 were $117,857. See Note 7 for additional information related to these warrants.

At October 31, 2021 and April 30, 2021, there were $5,000,000 and no outstanding borrowings, respectively, under the Credit Facility.

The Credit Facility Agreement contains customary representations and warranties and events of default. Pursuant to the Loan Agreement and the Revolving Note, all future or contemporaneous indebtedness incurred by the Company, other than indebtedness expressly permitted by the Credit Facility Agreement and the Revolving Note, will be subordinated to the Facility.

12

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2021

(Unaudited)

On March 6, 2019, the Company amended and restated the Credit Facility Agreement (the “Amended and Restated Facility Agreement”) and the Revolving Note. The Amended and Restated Facility Agreement provides among other things that the Company’s obligations thereunder are secured by a first priority lien in certain deposit accounts of the Company, all current and future accounts receivable of Aspen University and USU, certain of the deposit accounts of Aspen University and USU and all of the outstanding capital stock of Aspen University and USU.

Pursuant to the Credit Facility Agreement, on November 5, 2018 the Company issued to the Foundation warrants to purchase 92,049 shares of the Company’s common stock exercisable for five years from the date of issuance at the exercise price of $5.85 per share which were deemed to have a relative fair value of $255,071 (the "2018 Cooperman Warrants"). These warrants were exercised on June 8, 2020. The fair value of the warrants along with the upfront Facility fee were treated as debt issue cost assets to be amortized over the term of the loan, as the facility has not been drawn on. As a result of the aforementioned note extension, the remainder of the unamortized costs of $9,722 were written off during the quarter ended October 31, 2021. Total unamortized costs at October 31, 2021 and April 30, 2021 were $0 and $18,056, respectively.

Note 7. Stockholders’ Equity

AGI maintains two stock-based incentive plans: the 2012 Equity Incentive Plan (the “2012 Plan”) and 2018 Equity Incentive Plan (the “2018 Plan”) that provides for the grant of shares in the form of incentive stock options, non-qualified stock options, restricted shares, stock appreciation rights and RSUs to employees, consultants, officers and directors.

On December 30, 2020, the Company held its Annual Meeting of Shareholders at which the shareholders voted to amend the 2018 Plan to increase the number of shares of common stock available for issuance under the 2018 Plan from 1,100,000 to 1,600,000 shares.

As of October 31, 2021 and April 30, 2021 there were 171,459 and 549,739 shares remaining available for future issuance under the 2012 and the 2018 Plans, respectively.

Restricted Stock

As of October 31, 2021, there were 8,224 unvested shares of restricted common stock outstanding. During the six months ended October 31, 2021, there were no new restricted stock grants, forfeitures, vested stock or expirations. Total unrecognized compensation expense related to the unvested shares as of October 31, 2021 was $7,018, and is expected to be recognized over a weighted-average period of approximately 0.17 years.

Restricted Stock Units

A summary of the Company’s RSU activity during the six months ended October 31, 2021 is presented below:

Restricted Stock Units	Number of Shares	Weighted Average Grant Price
Unvested balance outstanding, April 30, 2021	549,972	$	6.58
Granted	412,792	6.16
Forfeits	(28,841)	9.80
Vested	(34,820)	6.15
Expired	—	—
Unvested balance outstanding, October 31, 2021	899,103	$	5.38

Of the 412,792 RSUs granted during the six months ended October 31, 2021, 410,000 RSUs correspond to executive compensation grants summarized below.

On August 16 2021, the Compensation Committee approved a 125,000 RSU grant to the Company’s newly hired Chief Financial Officer as part of the employment agreement. The grant has a grant date fair value of $725,000 based on a closing stock price of $5.80 per share. On August 12, 2021, the Compensation Committee approved individual grants of 80,000 RSUs

13

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2021

(Unaudited)

to the Company’s Chief Operating Officer and Chief Academic Officer. The grants have a total grant date fair value of $1.0 million based on a closing stock price of $6.48 per share.

The three executive grants discussed above are under the Company’s 2018 Equity Incentive Plan and are set to vest annually over a period of three years and are subject to continued employment as an officer of the Company on each applicable vesting date. The amortization expense related to these grants for the three months ended October 31, 2021 was $146,817 and is included in "general and administrative expense" in the accompanying consolidated statement of operations.

On July 21, 2021, as part of a new employment agreement, the Compensation Committee approved a 125,000 RSU grant to the Company's Chief Executive Officer under the Company's 2018 Equity Incentive Plan. The grant has a grant date fair value of $873,750 based on a closing stock price of $6.99 per share. As stipulated in the grant, vesting is subject to continued employment with the Company and will occur in full on the date the Company files with the SEC a quarterly or annual report on Forms 10-Q or 10-K, as applicable, which reflects the Company's reported net income on a GAAP basis. The Company expects this condition to be met in the fourth quarter of Fiscal 2022 and is amortizing the expense over one year through July 2022 (the filing date of the Form 10-K for Fiscal Year 2022). The Company will continue to assess the performance condition at each reporting period. If the RSUs do not vest within three years from the July 21, 2021 effective date, they will be forfeited. The amortization expense related to this grant for the three and six months ended October 31, 2021 was $72,813 and $218,438, respectively, which is included in general and administrative expense in the consolidated statements of operations.

The remaining 2,792 RSU grants during the six months ended October 31, 2021 were granted to employees and have a grant date fair value that ranges from $4.92 to $6.50 per share, or a total of $16,456, vesting annually over three years and subject to continued employment on each applicable vesting date.

Of the 899,103 unvested RSUs outstanding at October 31, 2021, there are 195,000 RSUs remaining from the February 4, 2020 executive grant. These RSUs vest four years from the grant date, if each applicable executive is still employed by the Company on the vesting date and subject to accelerated vesting for all RSUs if the closing price of the Company’s common stock is at least $12 for 20 consecutive trading days. On the grant date, the closing price of the Company's common stock on The Nasdaq Global Market was $9.49 per share. The amortization expense related to these transactions for the three and six months ended October 31, 2021 and 2020, was approximately $112,155 and $224,311, and $111,211 and $1.5 million, respectively, which is included in general and administrative expense in the consolidated statements of operations.

At October 31, 2021, total unrecognized compensation expense related to unvested RSUs is $4,839,604 and is expected to be recognized over a weighted-average period of approximately 1.57 years.

Warrants

The Company estimates the fair value of warrants utilizing the Black-Scholes pricing model, which is dependent upon several variables such as the expected term, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected term and expected dividend yield rate over the expected term. The Company believes this valuation methodology is appropriate for estimating the fair value of warrants issued to directors which are subject to ASC Topic 718 requirements. These amounts are estimates and thus may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants. The Company recognizes expense on a straight-line basis over the vesting period of each warrant issued.

14

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2021

(Unaudited)

A summary of the Company’s warrant activity during the six months ended October 31, 2021 is presented below:

Warrants	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Balance Outstanding, April 30, 2021	374,174	$	6.37	1.90	$	—
Granted	75,000	$	6.23	4.80	—
Exercised	—	$	—	—	—
Surrendered	—	$	—	—	—
Expired	—	$	—	—	—
Balance Outstanding, October 31, 2021	449,174	$	6.35	1.96	$	—
Exercisable, October 31, 2021	424,174	$	6.31	1.80	$	—

OUTSTANDING WARRANTS					EXERCISABLE WARRANTS
Exercise Price		Weighted Average Exercise Price		Outstanding No. of Warrants	Weighted Average Exercise Price		Weighted Average Remaining Life In Years	Exercisable No. of Warrants
$	4.89	$	4.89	50,000	$	4.89	2.44	50,000
$	5.85	$	5.85	50,000	$	5.85	4.84	50,000
$	6.00	$	6.00	100,000	$	6.00	2.35	100,000
$	6.87	$	6.87	224,174	$	6.87	0.73	224,174
$	6.99	$	6.99	25,000
				449,174				424,174

On August 31, 2021, the Compensation Committee approved the issuance of warrants to the Leon and Toby Cooperman Family Foundation as an extension fee in connection with the $5 million revolving line of credit. The warrants allow for the purchase of 50,000 shares of the Company’s common stock and have an exercise price of $5.85. The warrants have an exercise period of five years from the August 31, 2021 issuance date and will terminate automatically and immediately upon the expiration of the exercise period. The fair value of the warrants is $137,500 and is being amortized over the 14-month line of credit period. The Company has recognized $19,643 of amortization expense in connection with the fair value of the warrants for the three months ending October 31, 2021, which is included in "interest expense" in the accompanying consolidated statement of operations.

On July 21, 2021, the Compensation Committee approved warrants to a former member of the Board of Directors for the purchase of 25,000 shares of the Company's common stock with an exercise price of $6.99 per share. The warrants have an exercise period of five years from the July 21, 2021 issuance date and vest annually over a three year period subject to continued service on the Company's Advisory Board on each applicable vesting date. The warrants will terminate automatically and immediately upon the expiration of the exercise period. The fair value of the warrants is $84,000 and is being amortized over the three year vesting period. The Company has recognized $7,000 and $9,333 of amortization expense in connection with the fair value of the warrants for the three and six months ending October 31, 2021, respectively, which is included in “general and administrative” expense in the accompanying consolidated statement of operations.

During the three months ended July 31, 2020, there was a warrant modification and acceleration charge of $25,966 related to the exercise of 192,049 warrants by the Leon and Toby Cooperman Family Foundation, which was included in “other (expense) income, net” in the accompanying consolidated statement of operations.

On April 10, 2019, the Company issued warrants to an advisory board member for services to purchase 50,000 shares of the Company's common stock with an exercise price of $4.89 per share. The warrants have an exercise period of five years from the April 10, 2019 issuance date and vest annually over a three year period. The warrants will terminate automatically and immediately upon the expiration of the exercise period. The fair value of the warrants is $109,500 and is being amortized over

15

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2021

(Unaudited)

the three year vesting period. The Company has recognized $9,125 and $18,250 of amortization expense in connection with the fair value of the warrants for the three and six months ending October 31, 2021 and 2020, respectively, which is included in “general and administrative” expense in the accompanying consolidated statement of operations.

Stock Option Grants to Employees and Directors

The Company estimates the fair value of share-based compensation utilizing the Black-Scholes option pricing model, which is dependent upon several variables such as the expected option term, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected option term and expected dividend yield rate over the expected option term. The Company believes this valuation methodology is appropriate for estimating the fair value of stock options granted to employees and directors which are subject to ASC Topic 718 requirements. These amounts are estimates and thus may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants. The Company recognizes compensation on a straight-line basis over the requisite service period for each award.

The Company utilizes the simplified method to estimate the expected life for stock options granted to employees. The simplified method was used as the Company does not have sufficient historical data regarding stock option exercises. The expected volatility is based on historical volatility. The risk-free interest rate is based on the U.S. Treasury yields with terms equivalent to the expected life of the related option at the time of the grant. Dividend yield is based on historical trends. While the Company believes these estimates are reasonable, the compensation expense recorded would increase if the expected life was increased, a higher expected volatility was used, or if the expected dividend yield increased.

A summary of the Company’s stock option activity for employees and directors during the six months ended October 31, 2021, is presented below:

Options	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Balance Outstanding, April 30, 2021	1,214,473	$	6.24	1.88	$	204,719
Granted	—	—		—	—
Exercised	(216,752)	5.77		—	—
Forfeited	(4,419)	4.61		—	—
Expired	(1,252)	2.76		—	—
Balance Outstanding, October 31, 2021	992,050	$	6.61	1.56	$	172,313
Exercisable, October 31, 2021	928,457	$	6.72	1.51	$	161,584

Of the 216,752 options exercised for 46,908 common shares during the six months ended October 31, 2021, 200,000 were cashless options exercised by the Company’s Chief Operating Officer in September 2021. As part of this cashless transactions, 30,156 net shares were issued and 169,844 were retained by the Company.

During the three and six months ended October 31, 2021 and 2020, the Company received proceeds from the exercise of stock options for cash of $33,486 and $56,034 and $945,332 and $2,215,315, respectively.

16

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2021

(Unaudited)

OUTSTANDING OPTIONS				EXERCISABLE OPTIONS
Exercise Price	Weighted Average Exercise Price		Outstanding Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Life In Years	Exercisable Number of Options
$3.24 to $4.38	$	3.82	179,264	$	3.81	0.78	166,597
$4.50 to $5.20	$	4.94	153,944	$	5.00	1.99	111,019
$5.95 to $6.28	$	5.95	28,000	$	5.95	0.81	28,000
$7.17 to $7.55	$	7.45	473,093	$	7.46	1.82	465,092
$8.57 to $9.07	$	8.98	157,749	$	8.98	1.18	157,749
			992,050				928,457

As of October 31, 2021, there was approximately $28,670 of unrecognized compensation costs related to unvested stock options. That cost is expected to be recognized over a weighted-average period of approximately 0.92 year.

Stock-based compensation related stock options, RSUs and restricted stock

For the three and six months ended October 31, 2021, the Company recorded stock-based compensation expense of $722,158 and $1,264,870, respectively, which consisted of: $23,504 and $108,912, $688,129 and $1,134,906 and $10,525 and $21,052, respectively, in connection with stock options, RSUs and restricted stock, which is included in “general and administrative” expense in the unaudited consolidated statements of operations.

For the three and six months ended October 31, 2020, the Company recorded stock-based compensation expense of $1,831,548 and $2,318,658, respectively, which consisted of: $142,397 and $311,131, $1,678,622 and $1,986,474 and $10,529 and $21,053, respectively, in connection with stock options, RSUs and restricted stock, which is included in “general and administrative” expense in the unaudited consolidated statements of operations.

Treasury Stock

As of both October 31, 2021 and April 30, 2021, 155,486 shares of common stock were held in treasury representing shares of common stock surrendered upon the exercise of stock options in payment of the exercise prices and the taxes and similar amounts due arising from the option exercises. The value of these shares is approximately $1.8 million and represents the fair market value of shares surrendered as of the date of each applicable exercise date.

Note 8. Revenue

Revenue consists primarily of tuition and fees derived from courses taught by the Company online as well as from related educational resources that the Company provides to its students, such as access to our online materials and learning management system. The Company’s educational programs have starting and ending dates that differ from its fiscal quarters. Therefore, at the end of each fiscal quarter, a portion of revenue from these programs is not yet earned and is therefore deferred. The Company also charges students fees for library and technology costs, which are recognized over the related service period and are not considered separate performance obligations. Other services, books, and exam fees are recognized as services are provided or when goods are received by the student. The Company’s contract liabilities are reported as deferred revenue and due to students. Deferred revenue represents the amount of tuition, fees, and other student payments received in excess of the portion recognized as revenue and it is included in current liabilities in the accompanying consolidated balance sheets.

17

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2021

(Unaudited)

The following table represents our revenue disaggregated by the nature and timing of services:

	Three Months Ended October 31,				Six Months Ended October 31,
	2021		2020		2021		2020
Tuition - recognized over period of instruction	$	16,632,114	$	14,974,682	$	33,753,794	$	28,341,990
Course fees - recognized over period of instruction	1,982,771		1,786,364		3,986,111		3,386,057
Book fees - recognized at a point in time	15,018		46,037		42,777		85,175
Exam fees - recognized at a point in time	194,371		78,900		390,413		149,555
Service fees - recognized at a point in time	115,937		85,062		198,111		173,830
	$	18,940,211	$	16,971,045	$	38,371,206	$	32,136,607

Contract Balances and Performance Obligations

The Company recognizes deferred revenue as a student participates in a course which continues past the consolidated balance sheet date.

The deferred revenue balance as of April 30, 2021 was $6,825,014. During the six months ended October 31, 2021, the Company recognized $5,407,735 of revenue that was included in the deferred revenue balance as of April 30, 2021.

When the Company begins providing the performance obligation by beginning instruction in a course, a contract receivable is created, resulting in accounts receivable. The Company accounts for receivables in accordance with ASC 310, Receivables. The Company uses the portfolio approach.

Cash Receipts

Our students finance costs through a variety of funding sources, including, among others, monthly payment plans, installment plans, federal loan and grant programs (Title IV), employer reimbursement, and various veterans and military funding and grants, and cash payments. Most students elect to use our monthly payment plan. This plan allows them to make continuous monthly payments during the length of their program and through the length of their payment plan. Title IV and military funding typically arrives during the period of instruction. Students who receive reimbursement from employers typically do so after completion of a course. Students who choose to pay cash for a class typically do so before beginning the class.

Significant Judgments

We analyze revenue recognition on a portfolio approach under ASC 606-10-10-4. Significant judgment is utilized in determining the appropriate portfolios to assess for meeting the criteria to recognize revenue under ASC Topic 606. We have determined that all of our students can be grouped into one portfolio. Students behave similarly, regardless of their payment method. Enrollment agreements and refund policies are similar for all of our students. We do not expect that revenue earned for the portfolio is significantly different as compared to revenue that would be earned if we were to assess each student contract separately.

The Company maintains institutional tuition refund policies, which provides for all or a portion of tuition to be refunded if a student withdraws during stated refund periods. Certain states in which students reside impose separate, mandatory refund policies, which override the Company’s policy to the extent in conflict. If a student withdraws at a time when a portion or none of the tuition is refundable, then in accordance with its revenue recognition policy, the Company recognizes as revenue the tuition that was not refunded. Since the Company recognizes revenue pro-rata over the term of the course and because, under its institutional refund policy, the amount subject to refund is never greater than the amount of the revenue that has been deferred, under the Company’s accounting policies revenue is not recognized with respect to amounts that could potentially be refunded.

The Company had revenue from students outside the United States totaling approximately 1% of consolidated revenue for each of the three and six months ended October 31, 2021 and 2020.

18

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2021

(Unaudited)

Note 9. Leases

We determine if a contract contains a lease at inception. We have entered into operating leases totaling approximately 174,528 square feet of office and classroom space in Phoenix, San Diego, New York City, Denver, Austin, Tampa, Nashville and New Brunswick Province in Canada. These leases expire at various dates through April 2031, the majority contain annual base rent escalation clauses. Most of these leases include options to terminate for a fee or extend for additional five-year periods. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company does not have any financing leases.

As of October 31, 2021, our longer term operating leases are located in Tampa, Phoenix, Austin, and Nashville and are set to expire in seven to ten years. These leases make up 95% of the total future minimum lease payments.

Operating lease assets are right of use assets ("ROU assets"), which represent the right to use an underlying asset for the lease term. Operating lease liabilities represent the obligation to make lease payments arising from the lease. Operating leases are included in "Operating lease right of use assets, net", "Operating lease obligations, current portion" and "Operating lease obligations, less current portion" in the consolidated balance sheet at October 31, 2021 and April 30, 2021. These assets and lease liabilities are recognized based on the present value of remaining lease payments over the lease term. When the lease does not provide an implicit interest rate, the Company uses an incremental borrowing rate of 12% to determine the present value of the lease payments.

Lease incentives are deducted from the right of use assets. Incentives such as tenant improvement allowances are amortized as leasehold-improvements, separately, over the life of the lease term. For the three and six months ended October 31, 2021 and 2020, the amortization expense for these tenant improvement allowances was $152,499 and $0 and $302,887 and $0, respectively.

Lease expense for operating leases is recognized on a straight-line basis over the lease term. Lease expense for the three and six months ended October 31, 2021 and 2020 was $916,435 and $664,415 and $1,853,172 and $1,061,653, respectively, which is included in general and administrative expenses in the consolidated statements of operations.

ROU assets are summarized below:

	October 31, 2021		April 30, 2021
ROU assets - Operating facility leases	$	15,958,721	$	14,308,296
Less: accumulated reduction	(2,448,065)		(1,593,433)
Total ROU assets	$	13,510,656	$	12,714,863

Operating lease obligations, related to the ROU assets are summarized below:

	October 31, 2021		April 30, 2021
Total lease liabilities	$	22,436,658	$	19,946,229
Reduction of lease liabilities	(2,558,744)		(1,617,600)
Total operating lease obligations	$	19,877,914	$	18,328,629

19

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2021

(Unaudited)

The following is a schedule by fiscal years of future minimum lease payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of one year as of October 31, 2021 (a) (by fiscal year) .

Maturity of Lease Obligations	Lease Payments
2022 (remaining)	$	2,179,605
2023	4,142,637
2024	4,018,977
2025	3,802,959
2026	3,908,722
Thereafter	11,963,225
Total future minimum lease payments	30,016,125
Less: imputed interest	(10,138,211)
Present value of operating lease liabilities	$	19,877,914

_____________________

(a) Lease payments exclude $3.7 million of legally binding minimum lease payments for the new BSN Pre-Licensure campus location in a Tier 1 metropolitan area lease signed but not yet commenced.

Balance Sheet Classification	October 31, 2021		April 30, 2021
Operating lease obligations, current portion	$	2,145,431	$	2,029,821
Operating lease obligations, less current portion	17,732,483		16,298,808
Total operating lease liabilities	$	19,877,914	$	18,328,629

Other Information	October 31, 2021
Weighted average remaining lease term (in years)	7.29
Weighted average discount rate	12	%

Note 10. Income Taxes

The Company determined that it has a permanent establishment in Canada, as defined by article V(2)(c) of the Convention between Canada and the United States of America with Respect to Taxes on Income and on Capital (the “Treaty”), which would be subject to Canadian taxation as levied under the Income Tax Act. The Company has filed Canadian T2 Corporation Income Tax Returns and related information returns under the Voluntary Disclosure Program with the Canada Revenue Agency ("CRA") to cover the 2013 through 2021 tax years during which a permanent establishment may have been in place. As of October 31, 2021, the CRA has not yet responded to the voluntary disclosure. The Company will also file an annual Canadian T2 Corporation Income Tax return to report the ongoing activity of the permanent establishment for the 2022 and future taxation years.

As of October 31, 2021, the Company recorded a reserve of approximately $150,000 for the estimate of a multi-year foreign income tax liability.

Note 11. Commitments and Contingencies

Employment Agreements

From time to time, the Company enters into employment agreements with certain of its employees. These agreements typically include bonuses, some of which may or may not be performance-based in nature.

Legal Matters

20

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2021

(Unaudited)

From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of October 31, 2021, except as discussed below, there were no other pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of our consolidated operations and there are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

On February 11, 2013, HEMG, and its Chairman, Mr. Patrick Spada, sued the Company, certain senior management members and our directors in state court in New York seeking damages arising principally from (i) allegedly false and misleading statements in the filings with the SEC and the DOE where the Company disclosed that HEMG and Mr. Spada borrowed $2.2 million without board authority, (ii) the alleged breach of an April 2012 agreement whereby the Company had agreed, subject to numerous conditions and time limitations, to purchase certain shares of the Company from HEMG, and (iii) alleged diminution to the value of HEMG’s shares of the Company due to Mr. Spada’s disagreement with certain business transactions the Company engaged in, all with Board approval.

On December 10, 2013, the Company filed a series of counterclaims against HEMG and Mr. Spada in the same state court of New York. By order dated August 4, 2014, the New York court denied HEMG and Spada’s motion to dismiss the fraud counterclaim the Company asserted against them.

In November 2014, the Company and Aspen University sued HEMG seeking to recover sums due under two 2008 Agreements where Aspen University sold course materials to HEMG in exchange for long-term future payments. On September 29, 2015, the Company and Aspen University obtained a default judgment in the amount of $772,793. This default judgment precipitated the bankruptcy petition discussed in the next paragraph.

On July 21, 2021, the bankruptcy trustee paid the Company $498,120 based on assets available in the trust, which is included in "other income (expense), net" in the accompanying consolidated statements of operations. As a result, the Company wrote off the net receivable of $45,329, described in Note 5, at July 31, 2021. No further assets are available for distribution. At some point, the New York state court litigation may resume.

Regulatory Matters

The Company’s subsidiaries, Aspen University and United States University, are subject to extensive regulation by Federal and State governmental agencies and accrediting bodies. In particular, the Higher Education Act (the “HEA”) and the regulations promulgated thereunder by the DOE subject the subsidiaries to significant regulatory scrutiny on the basis of numerous standards that schools must satisfy to participate in the various types of federal student financial assistance programs authorized under Title IV of the HEA.

On August 22, 2017, the DOE informed Aspen University of its determination that the institution has qualified to participate under the HEA and the Federal student financial assistance programs (Title IV, HEA programs) and set a subsequent program participation agreement reapplication date of March 31, 2021. On April 16, 2021, the DOE granted provisional certification for a two-year timeframe, and set a subsequent program participation reapplication date of September 30, 2023.

USU currently has provisional certification to participate in the Title IV Programs due to its acquisition by the Company. The provisional certification allows the school to continue to receive Title IV funding as it did prior to the change of ownership. The provisional certification expired on December 31, 2020. While the institution submitted its recertification application timely in October 2020, the DOE has not issued its final certification. The institution is able to continue operating under its current participation agreement until the DOE issues its recertification.

The HEA requires accrediting agencies to review many aspects of an institution's operations in order to ensure that the education offered is of sufficiently high quality to achieve satisfactory outcomes and that the institution is complying with accrediting standards. Failure to demonstrate compliance with accrediting standards may result in the imposition of probation, the requirements to provide periodic reports, the loss of accreditation or other penalties if deficiencies are not remediated.

Because our subsidiaries operate in a highly regulated industry, each may be subject from time to time to audits, investigations, claims of noncompliance or lawsuits by governmental agencies or third parties, which allege statutory violations, regulatory infractions or common law causes of action.

21

ASPEN GROUP, INC. AND SUBSIDIARIES

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

October 31, 2021

(Unaudited)

Title IV Funding

Aspen University and United States University derive a portion of their revenue from financial aid received by its students under programs authorized by Title IV of the HEA, which are administered by the US Department of Education. When students seek funding from the federal government, they receive loans and grants to fund their education under the following Title IV Programs: (1) the Federal Direct Loan program, or Direct Loan; (2) the Federal Pell Grant program, or Pell; (3) Federal Work Study and (4) Federal Supplemental Opportunity Grants. For the fiscal year ended April 30, 2021, 44.72% of Aspen University’s and 33.81% for United States University's cash-basis revenue for eligible tuition and fees were derived from Title IV Programs.

Return of Title IV Funds

An institution participating in Title IV Programs must correctly calculate the amount of unearned Title IV Program funds that have been disbursed to students who withdraw from their educational programs before completion and must return those unearned funds in a timely manner, no later than 45 days of the date the school determines that the student has withdrawn. Under the DOE regulations, failure to make timely returns of Title IV Program funds for 5% or more of students sampled on the institution's annual compliance audit in either of its two most recently completed fiscal years can result in the institution having to post a letter of credit in an amount equal to 25% of its required Title IV returns during its most recently completed fiscal year. If unearned funds are not properly calculated and returned in a timely manner, an institution is also subject to monetary liabilities or an action to impose a fine or to limit, suspend or terminate its participation in Title IV Programs.

On September 28, 2020, the DOE notified USU that the funds held for a letter of credit in the amount of $255,708, based on the audited same day balance sheet requirements that apply in a change of control, which was funded by the University’s sole shareholder, AGI, were released. In August 2020, the DOE informed USU that it is required to post a new letter of credit in the amount of $379,345, based on the current level of Title IV funding. This irrevocable letter of credit was to expire on August 25, 2021. Pursuant to USU’s provisional Program Participation Agreement ("PPA"), the DOE indicated that USU must agree to participate in Title IV under the HCM1 funding process; however, the DOE does retain discretion on whether or not to implement that term of the agreement. Although DOE has not, to date, notified USU that it has been placed in the HCM1 funding process, nor does the DOE’s public disclosure website identify USU as being on HCM1, it is possible that prior to the end of the PPA term, the DOE may notify USU that it must begin funding under the HCM1 procedure. If this occurs, the Company believes this will not have a material impact on the consolidated financial statements. In December 2020, the DOE reduced USU's existing letter of credit by $369,473, which was required to be posted based on the level of Title IV funding. In connection with USU's most recent Compliance Audit, USU currently maintains a letter of credit of $9,872 at October 31, 2021.

Approval to Confer Degrees

Aspen University is a Delaware corporation and is approved to operate in the State of Delaware. Aspen University is authorized by the Colorado Commission on Education in the State of Colorado and the Arizona State Board for Private Post-Secondary Education in the State of Arizona to operate as a degree granting institution for all degrees. Aspen University is authorized to operate as a degree granting institution for bachelor degrees by the Texas Higher Education Coordinating Board in the State of Texas. Aspen University has been granted Optional Expedited Authorization as a postsecondary educational institution in Tennessee for its Bachelor of Science in Nursing (Pre-Licensure) degree program. Aspen University has received a Provisional License for its Bachelor of Science in Nursing (Pre-Licensure) degree program to operate in the state of Florida by the Commission for Independent Education of the Florida Department of Education and is in the process for full licensure.

USU is also a Delaware corporation and received initial approval from the Delaware DOE to confer degrees through June 2023. United States University is authorized by the California Bureau of Private Postsecondary Education and the Arizona State Board for Private Post-Secondary Education to operate as degree granting institutions for all degrees.

22

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

You should read the following discussion in conjunction with our unaudited consolidated financial statements, which are included elsewhere in this Form 10-Q. This Quarterly Report on Form 10-Q contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. See "Cautionary Note Regarding Forward Looking Statements" for more information.

Key Terms

In connection with the management of our businesses, we identify, measure and assess a variety of operating metrics. The principal metrics we use in managing our businesses are set forth below:

Operating Metrics

•Lifetime Value ("LTV") - Lifetime Value as the weighted average total amount of tuition and fees paid by every new student that enrolls in the Company’s universities, after giving effect to attrition.

•Bookings - defined by multiplying LTV by new student enrollments for each operating unit.

•Average Revenue per Enrollment ("ARPU") - defined by dividing total bookings by total enrollments for each operating unit.

Operating costs and expenses

•Cost of revenue - consists of instructional costs and services and marketing and promotional costs.

◦Instructional costs - consist primarily of costs related to the administration and delivery of the Company's educational programs. This expense category includes compensation costs associated with online faculty, technology license costs and costs associated with other support groups that provide services directly to the students and are included in cost of revenue.

◦Marketing and promotional costs - include costs associated with producing marketing materials and advertising, and outside sales costs. Such costs are generally affected by the cost of advertising media, the efficiency of the Company's marketing and recruiting efforts, and expenditures on advertising initiatives for new and existing academic programs. Non-direct response advertising activities are expensed as incurred, or the first time the advertising takes place, depending on the type of advertising activity and are included in cost of revenue.

•General and administrative expense - consists primarily of compensation expense (including stock-based compensation expense) and other employee-related costs for personnel engaged in executive and academic management and operations, finance, legal, tax, information technology and human resources, fees for professional services, financial aid processing costs, non-capitalizable courseware and software costs, corporate taxes and facilities costs.

Non-GAAP financial measures:

•Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA") - is a non-GAAP financial measure. See "Non-GAAP Financial Measures" for a reconciliation of net loss to EBITDA for the three and six months ended October 31, 2021 and 2020.

•Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("Adjusted EBITDA") - is a non-GAAP financial measure. See "Non-GAAP Financial Measures" for a reconciliation of net loss to Adjusted EBITDA for the three and six months ended October 31, 2021 and 2020.

•Adjusted EBITDA Margin - is a non-GAAP financial measure. See "Non-GAAP Financial Measures" for a reconciliation of net loss to Adjusted EBITDA for the three and six months ended October 31, 2021 and 2020.

23

Company Overview

Aspen Group, Inc. is an education technology holding company. It operates two universities, Aspen University Inc. ("Aspen University") and United States University Inc. ("United States University" or "USU").

All references to the “Company”, “AGI”, “Aspen Group”, “we”, “our” and “us” refer to Aspen Group, Inc., unless the context otherwise indicates.

AGI leverages its education technology infrastructure and expertise to allow its two universities, Aspen University and United States University, to deliver on the vision of making college affordable again. Because we believe higher education should be a catalyst to our students’ long-term economic success, we exert financial prudence by offering affordable tuition that is one of the greatest values in higher education. AGI’s primary focus relative to future growth is to target the high growth nursing profession.

In March 2014, Aspen University began offering monthly payment plans available to all students across every online degree program offered by Aspen University. The monthly payment plan is designed so that students will make one payment per month, and that monthly payment is applied towards the total cost of attendance (tuition and fees, excluding textbooks). The monthly payment plan offers online undergraduate students the opportunity to pay their tuition and fees at $250/month, online master students $325/month, and online doctoral students $375/month, interest free, thereby giving students a monthly payment option versus taking out a federal financial aid loan.

USU began offering monthly payment plans in the summer of 2017. Today, monthly payment plans are available for the online RN to BSN program ($250/month), online MBA/MAEd/MSN programs ($325/month), online hybrid Bachelor of Arts in Liberal Studies, Teacher Credentialing tracks approved by the California Commission on Teacher Credentialing ($350/month), and the MSN-FNP program ($375/month).

Since 1993, Aspen University has been nationally accredited by the DEAC, a national accrediting agency recognized by the Department of Education and the Council for Higher Education Accreditation. On February 25, 2019, the DEAC informed Aspen University that it had renewed its accreditation for five years to January 2024.

Since 2009, USU has been regionally accredited by WSCUC.

Both universities are qualified to participate under the Higher Education Act and the Federal student financial assistance programs (Title IV, HEA programs).

AGI Student Population Overview

AGI’s overall active degree-seeking student body (includes both Aspen University and USU) grew 8% year-over-year to 14,318 as of October 31, 2021 from 13,238 as of October 31, 2020 and students seeking nursing degrees were 12,442 or 87% of total active students at both universities. Of the 12,442 students seeking nursing degrees, 9,942 are Registered Nurses (RNs) studying to earn an advanced degree, including 7,031 at Aspen University and 2,911 at USU, while the remaining 2,500 nursing students are enrolled in Aspen University’s BSN Pre-Licensure program in the Phoenix, Austin, Tampa and Nashville metros.

The chart below shows five quarters of active student body results. Active student body is comprised of active degree-seeking students, enrolled in a course at the end of the second quarter of fiscal year 2022 or are registered for an upcoming course.

24

AGI New Student Enrollments

New student enrollments at AU grew sequentially by 9% primarily as a result of rising enrollments in the three new pre-licensure metros (Austin, Nashville and Tampa). AU year-over-year new enrollments were down 13% as a result of the planned reduction of BSN Pre-Licensure enrollments in the Phoenix metro year-over-year and the impact of COVID-19 (specifically the effect the Delta variant surge has had among prospective RN students starting in June 2021). New student enrollments at USU decreased by 7% sequentially and 3% year-over-year, from 649 a year ago to 630. New RN student enrollments at USU were similarly impacted by COVID-19.

On a Company-wide basis, new student enrollments increased sequentially from 2,276 to 2,380 or 5%, primarily as a result of sequential enrollment growth in the three new pre-licensure metros. On a year-over-year basis, new student enrollments for the Company were down 10% due to the planned enrollment reduction in the Phoenix pre-licensure metro and the COVID-19 impact.

New student enrollments for the past five quarters are shown below:

	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22
Aspen University	2,010	1,593	1,593	1,601	1,750
USU	649	536	589	675	630
Total	2,659	2,129	2,182	2,276	2,380

Bookings Analysis and ARPU

On a year-over-year basis, Q2 Fiscal 2022 Bookings decreased 11%, to $37.4 million from $42.1 million in the prior year. As previously discussed, the proactive Phoenix pre-licensure enrollment reduction and recent COVID surge caused Bookings to decrease year-over-year.

	Second Quarter Bookings1 and Average Revenue Per Enrollment (ARPU)1
	Q2'21 Enrollments	Q2'21 Bookings 1		Q2'22 Enrollments	Q2'22 Bookings 1		Percent Change Total Bookings & ARPU 1
Aspen University	2,010	$	30,514,200	1,750	$	26,134,500
USU	649	$	11,565,180	630	$	11,226,600
Total	2,659	$	42,079,380	2,380	$	37,361,100	(11)	%
ARPU		$	15,825		$	15,698	(1)	%

_____________________

1 “Bookings” are defined by multiplying Lifetime Value (LTV) by new student enrollments for each operating unit. “Average Revenue Per Enrollment” (ARPU) is defined by dividing total Bookings by total new student enrollments for each operating unit.

25

During the Q2 Fiscal 2022, the Company continued to focus its growth capital almost exclusively on its two licensure degree programs which have higher lifetime values. Set forth below is the description of these two key licensure degree programs.

Bachelor of Science in Nursing (BSN) Pre-Licensure Program

Aspen University offers a Bachelor of Science in Nursing Pre-Licensure degree program (the “BSN Pre-Licensure Program”). This innovative hybrid (online/on-campus) program allows most of the credits to be completed online (83 of 120 credits or 69%), with pricing offered at current low tuition rates of $150/credit hour for online general education courses, $325/credit hour for online core nursing courses, and $495 for core clinical and clinical lab courses. For students with no prior college credits, the total cost of attendance is less than $50,000.

Phoenix, AZ Campus Locations

Aspen University began offering the BSN Pre-Licensure program in July 2018 at its initial campus in Phoenix, Arizona. As a result of overwhelming demand in the Phoenix metropolitan area, in January 2019 Aspen University began offering both day (July, November, March) and evening/weekend (January, May, September) terms, equaling six term starts per year. In September 2019, Aspen University opened a second campus in the Phoenix metropolitan area in partnership with HonorHealth.

Due to the significant demand in the Phoenix metro, on February 2, 2021, the Company began implementing its first double cohort enrollment at its main campus in Phoenix.

BSN Pre-Licensure Campus Locations Opened in Fiscal Year 2021

Austin, TX

Aspen University’s BSN Pre-Licensure program in Austin is based in the Frontera Crossing office building located at 101 W. Louis Henna Boulevard in the suburb of Round Rock. The building is situated at the junction of Interstate 35 and State Highway 45, one of the most heavily trafficked freeway exchanges in the metropolitan area with visibility to approximately 143,362 cars per day. Aspen University's initial PPN nursing student enrollments began on the September 29, 2020 semester start date.

Tampa, FL

Aspen University’s BSN Pre-Licensure program in Tampa is located at 12802 Tampa Oaks Boulevard. The building is visible from the intersection of Interstate 75 and East Fletcher Avenue, near the University of South Florida, providing visibility to approximately 126,500 cars per day. Aspen University's initial PPN nursing student enrollments began on the December 8, 2020 semester start date.

Nashville, TN

On March 8, 2021, the Company announced that Aspen University received the final required state and board of registered nursing regulatory approvals for their new BSN Pre-Licensure campus location in Nashville, Tennessee, with permission to commence marketing and begin to enroll first-year PPN students effective immediately. Aspen University's initial PPN nursing student enrollments began on the April 27, 2021 semester start date.

USU Master of Science in Nursing-Family Nurse Practitioner (MSN-FNP)

USU offers a number of nursing degree programs and other degree programs in health sciences, business & technology and education. Its primary enrollment program is its MSN-FNP which is designed for BSN-prepared registered nurses who are seeking a Nurse Practitioner license. The MSN-FNP is an online-hybrid 48-credit degree program with 100% of the curriculum online, including the curricular component to complete 540 clinical and 32 lab hours.

While MSN-FNP lab hours have been done at USU’s San Diego facility through the end of calendar 2020, the rapid growth of the MSN-FNP program has caused AGI to open two additional immersion locations in 2021. Specifically, the Company built-out an additional suite on the ground floor of our main facility in Phoenix (by the airport). Consequently, students now have the option to attend their weekend immersions at three different metro locations: San Diego, Phoenix and Tampa.

Accounts Receivable - Monthly Payment Plan ("MPP")

26

The Company offers several payment options to its students including monthly payment plan (MPP), installment plans and financial aid. Our growth in accounts receivable over the last several years has predominantly been a result of students taking advantage of our groundbreaking monthly payment plan which we introduced in 2014 at Aspen University and subsequently in Fiscal Year 2018 at USU. At October 31, 2021, Gross MPP accounts receivable was 86% of total gross accounts receivable. Of the Gross MPP accounts receivable, 50% was generated at each AU and USU.

The Monthly Payment Plan, offered by both Aspen University and United State University, is a private education loan with a 0% fixed rate of interest (0% APR) and no down payment. Each month the student will make one payment of $250, $325, $350 or $375 (depending on the program) until the program is paid for. The attractive aspect of being able to pay for a degree over a fixed period of time has fueled the growth of this plan. MPP is designed so students can build the cost of their degree into their monthly budget.

Long-Term Accounts Receivable

When a student signs up for the monthly payment plan, there is a contractual amount that the Company can expect to earn over the life of the student’s program. This full contractual amount cannot be recorded as an account receivable upon enrollment. As a student takes a class, revenue is earned over that eight-week class. Some students accelerate their program, taking two classes every eight-week period, and that increases the student’s accounts receivable balance. If any portion of that balance will be paid in a period greater than 12 months, that portion is reflected as long-term accounts receivable.

As a result of the growing acceptance of our monthly payment plans, our long-term accounts receivable balance has grown from $10,249,833 at April 30, 2021 to $12,663,815 at October 31, 2021. These are MPP students who make monthly payments over 36, 39 and 72 months. The average student completes their academic program in 30 months; therefore, most of the Company’s accounts receivable are short-term. However, when students graduate earlier than the 30 month average completion duration, they transition to long-term accounts receivable. This is the primary factor that has driven an increase in long-term accounts receivable.

Here is a graphic of both short-term and long-term receivables, as well as contractual value:

A	B	C
Payments owed for classes taken where payment plans for classes are less than 12 months, less monthly payments received	Payments owed for classes taken where payment plans are greater than 12 months	Expected classes to be taken over balance of program.
Short-Term Accounts Receivable	Long-term Accounts Receivable	Not recorded in financial statements
The Sum of A, B and C will equal the total cost of the program.

COVID-19 Update

Nursing students represented 87% or 12,442 of the Company’s total student body of 14,318 students at the end of the second quarter of fiscal 2022. Of the 12,442 nursing students, 2,500 are BSN Pre-Licensure students located across our four metro locations (Phoenix, Austin, Tampa and Nashville). The remaining 9,942 nursing students are licensed registered nurses (RNs) studying to earn an advanced degree (RN to BSN, MSN, MSN-FNP or DNP degree programs). Therefore. these 9,942 post-licensure nursing students represent 69% of the Company’s total student body and are the population of AGI students primarily affected by the COVID-19 pandemic.

Starting in the second half of June 2021 and continuing through October 2021, the Company saw lower course starts than seasonally expected among our RN student body. For example, at Aspen University, course starts among RNs from June through October increased by approximately 3% year-over-year. By comparison, over the previous two full fiscal years (Fiscal year 2021 and Fiscal Year 2020), course starts among RNs at Aspen University increased by an average of approximately 10% year-over-year.

In terms of new student enrollments, the Company saw enrollment growth on a quarterly sequential basis in all BSN Pre-Licensure metros as these prospective students continue to communicate a strong desire to enter the nursing profession. However, aggregate enrollments among RNs at both Aspen University and United States University were relatively flat on a quarterly sequential basis.

27

We cannot be certain what impact the Delta variant and other variants will have on the Company’s results as we progress through the second half of fiscal 2022.

Although COVID has had an impact on the Company’s short-term growth rate, we continue to execute the Aspen 2.0 business plan, which decreases advertising spend on our lower efficiency unit and shifts that spend to the higher efficiency business units. Aspen 2.0 is designed to support growth in our new pre-licensure metros and the USU Master of Nursing-Family Nurse Practitioner (“FNP”) program and was intended to allow us to achieve profitability by the end of fiscal 2022. Notwithstanding the impact of Covid headwinds in the current quarter, the Company continues to pursue its goal of break even on a GAAP basis for the fourth quarter.

Results of Operations

Set forth below is the discussion of the results of operations of the Company for the three months ended October 31, 2021 (“Q2 Fiscal 2022”) compared to the three months ended October 31, 2020 (“Q2 Fiscal 2021”), and for the six months ended October 31, 2021 (“1H Fiscal 2022”) compared to the six months ended October 31, 2020 (“1H Fiscal 2021”)

The following table presents selected consolidated statement of operations as a percentage of revenue (differences due to rounding):

	Three Months Ended October 31,				Six Months Ended October 31,
	2021		2020		2021		2020
Revenue	100	%	100	%	100	%	100	%
Operating expenses:
Cost of revenue (exclusive of depreciation and amortization shown separately below)
Instructional costs and services	26	%	22	%	24	%	21	%
Marketing and promotional costs	21	%	21	%	21	%	20	%
Total cost of revenue (exclusive of depreciation and amortization shown separately below)	46	%	43	%	45	%	41	%
General and administrative	61	%	66	%	59	%	62	%
Bad debt expense	2	%	4	%	2	%	3	%
Depreciation and amortization	4	%	3	%	4	%	3	%
Total operating expenses	114	%	116	%	110	%	110	%
Operating loss	(14)	%	(16)	%	(10)	%	(10)	%
Other income (expense):
Interest expense	(1)	%	(9)	%	—	%	(6)	%
Other (expense) income, net	—	%	—	%	1	%	—	%
Total other (expense) income, net	(1)	%	(9)	%	1	%	(7)	%
Loss before income taxes	(15)	%	(26)	%	(9)	%	(16)	%
Income tax expense	—	%	—	%	—	%	—	%
Net loss	(15)	%	(26)	%	(10)	%	(17)	%

28

Revenue

	Three Months Ended October 31,							Six Months Ended October 31,
	2021		$ Change		% Change	2020		2021		$ Change		% Change	2020
AU	$	12,758,851	$	705,141	6%	$	12,053,710	$	26,008,502	$	3,234,150	14%	$	22,774,352
USU	6,181,360		1,264,025		26%	4,917,335		12,362,704		3,000,449		32%	9,362,255
Revenue	$	18,940,211	$	1,969,166	12%	$	16,971,045	$	38,371,206	$	6,234,599	19%	$	32,136,607

Q2 Fiscal 2022 compared to Q2 Fiscal 2021

AU revenue increased 6% in Q2 Fiscal 2022 compared to Q2 Fiscal 2021 due primarily to Aspen’s BSN Pre-Licensure program, the AU degree program with the highest LTV.

USU revenue increased 26% in Q2 Fiscal 2022 compared to Q2 Fiscal 2021 due primarily to USU's MSN-FNP program, the USU degree program with the highest LTV.

The Company expects the majority of its revenue growth in future periods to be derived from these two degree programs as we continue prioritizing our highest LTV degree programs to achieve our long-term growth plans.

1H Fiscal 2022 compared to 1H Fiscal 2021

AU and USU revenue increased 14% and 32% in 1H Fiscal 2022 compared to 1H Fiscal 2021, respectively, primarily due to the factors described above in the three month discussion.

Cost of revenue (exclusive of depreciation and amortization shown separately below)

	Three Months Ended October 31,				Six Months Ended October 31,
	2021	$ Change	% Change	2020	2021	$ Change	% Change	2020
Cost of Revenue (exclusive of depreciation and amortization shown separately below)	$8,789,201	$1,464,421	20%	$7,324,780	$17,382,769	$4,210,466	32%	$13,172,303

Q2 Fiscal 2022 compared to Q2 Fiscal 2021

Instructional Costs and Services

Consolidated instructional costs and services for Q2 Fiscal 2022 increased to $4,836,461 or 26% of revenue from $3,726,248 or 22% of revenue for Q2 Fiscal 2021, an increase of $1,110,213 or 30%.

AU instructional costs and services was 26% and 20% of AU revenue for Q2 Fiscal 2022 and Q2 Fiscal 2021, respectively. As a percentage of revenue, instructional costs and services increased due primarily to an increase in faculty compensation costs related to the faculty hiring in the BSN Pre-Licensure campus locations in Phoenix, Austin, Tampa and Nashville, and increases in books and other educational materials.

USU instructional costs and services was 25% and 26% of USU revenue for Q2 Fiscal 2022 and Q2 Fiscal 2021, respectively.

Marketing and Promotional

Consolidated marketing and promotional costs for Q2 Fiscal 2022 were $3,952,740 or 21% of revenue compared to $3,598,532 or 21% of revenue for Q2 Fiscal 2021, an increase of $354,208 or 10%. Consolidated marketing and promotional costs remained at 21% of revenue in Q2 Fiscal 2022 and Q2 Fiscal 2021.

AU marketing and promotional costs represented 20% of AU revenue for both Q2 Fiscal 2022 and Q2 Fiscal 2021, respectively.

USU marketing and promotional costs was 16% and 18% of USU revenue for Q2 Fiscal 2022 and Q2 Fiscal 2021, respectively.

29

Corporate marketing costs were $342,719 for Q2 Fiscal 2022 compared to $274,552 for Q2 Fiscal 2021, an increase of $68,167 or 25%.

1H Fiscal 2022 compared to 1H Fiscal 2021

Instructional Costs and Services

Consolidated instructional costs and services for 1H Fiscal 2022 increased to $9,336,474 or 24% of revenue from $6,782,961 or 21% of revenue for 1H Fiscal 2021, an increase of $2,553,513 or 38%.

AU instructional costs and services were 24% and 20% of AU revenue for 1H Fiscal 2022 and 1H Fiscal 2021, respectively. As a percentage of revenue, instructional costs and services increased primarily due to the factors described above in the three month discussion.

USU instructional costs and services was 24% of USU revenue for both 1H Fiscal 2022 and 1H Fiscal 2021.

Marketing and Promotional

Consolidated marketing and promotional costs for 1H Fiscal 2022 were $8,046,295 or 21% of revenue compared to $6,389,342 or 20% of revenue for 1H Fiscal 2021, an increase of $1,656,953 or 26%.

AU marketing and promotional represented 21% and 19% of AU revenue for 1H Fiscal 2022 and 1H Fiscal 2021, respectively. As a percentage of revenue, marketing and promotional costs increased due primarily to the planned advertising spending increase throughout Fiscal Year 2022, targeted primarily to our highest LTV program. The majority of the year-over-year advertising spending increase is directed to the new pre-licensure metro locations: Austin, Nashville and Tampa.

USU marketing and promotional costs was 16% of USU revenue for both 1H Fiscal 2022 and 1H Fiscal 2021.

Corporate marketing and promotional costs was $666,984 in 1H Fiscal 2022 compared to $507,403 in 1H Fiscal 2021, an increase of $159,581or 31%, due primarily to the factor described above in the three month discussion.

General and administrative

	Three Months Ended October 31,				Six Months Ended October 31,
	2021	$ Change	% Change	2020	2021	$ Change	% Change	2020
General and administrative	$11,641,312	$356,157	3%	$11,285,155	$22,587,789	$2,508,878	12%	$20,078,911

Q2 Fiscal 2022 compared to Q2 Fiscal 2021

AU general and administrative expense was 36% and 32% of AU revenue for Q2 Fiscal 2022 and Q2 Fiscal 2021, respectively. As a percentage of revenue, general and administrative expense increased due primarily to increases in compensation, facilities and professional fees related to new campus openings, partially offset by a decrease in merchant fees.

USU general and administrative costs was 41% and 43% of USU revenue for Q2 Fiscal 2022 and Q2 Fiscal 2021, respectively. As a percentage of revenue, general and administrative expense decreased due primarily to a decrease in compensation, partially offset by an increase in facilities costs.

Corporate general and administrative costs was $4.5 million in Q2 Fiscal 2022 and $5.3 million in Q2 Fiscal 2021, a decrease of $0.8 million, or 15%. The decrease was primarily due to decreases in compensation and other employee-related costs, merchant fees and taxes, partially offset by increases in professional fees and travel expense.

1H Fiscal 2022 compared to 1H Fiscal 2021

AU general and administrative expense was 35% and 32% of Aspen University revenue for 1H Fiscal 2022 and 1H Fiscal 2021, respectively. As a percentage of revenue, general and administrative expense increased due primarily to the factors described above in the three month discussion.

30

USU general and administrative expense was 40% and 42% of USU revenue for 1H Fiscal 2022 and 1H Fiscal 2021, respectively. As a percentage of revenue, general and administrative expense decreased due primarily to the factor described above in the three month discussion.

Corporate general and administrative expense was $8.6 million in 1H Fiscal 2022 and $8.8 million 1H Fiscal 2021, a decrease of $0.2 million, or 2%. The decrease was primarily due to the factors described above in the three month discussion, and increases in insurance expense, which includes the annual renewal period.

Bad debt expense

	Three Months Ended October 31,				Six Months Ended October 31,
	2021	$ Change	% Change	2020	2021	$ Change	% Change	2020
Bad debt expense	$350,000	$(282,000)	(45)%	$632,000	$700,000	$(332,000)	(32)%	$1,032,000

For both the three and six months ended October 31, 2021 compared to the three and six months ended October 31, 2020, bad debt expense decreased as a percentage of total revenue. Based on our review of accounts receivable and historical write-off trends, the Company evaluated its reserve methodology and adjusted reserves for AU and USU accordingly. At AU and USU, approximately $230,000 and $30,000 of student accounts receivable were written off against the accounts receivable allowance during 1H Fiscal 2022.

Depreciation and amortization

	Three Months Ended October 31,				Six Months Ended October 31,
	2021	$ Change	% Change	2020	2021	$ Change	% Change	2020
Depreciation and amortization	$817,234	$290,877	55%	$526,357	$1,596,643	$579,662	57%	$1,016,981

For both the three and six months ended October 31, 2021, the increase in depreciation is primarily due to investments in new campuses, including capital expenditures of leasehold improvements and computer equipment, and an increase in amortization of internally developed capitalized software placed into service to support the Company's services and the opening of new campuses, partially offset by a decrease of fully depreciated assets.

Other (expense) income, net

	Three Months Ended October 31,				Six Months Ended October 31,
	2021	$ Change	% Change	2020	2021	$ Change	% Change	2020
Other (expense) income, net	$(188,822)	$1,347,926	(88)%	$(1,536,748)	$329,759	$2,445,262	NM	$(2,115,503)

________________________________

NM - Not meaningful

Q2 Fiscal 2022 compared to Q2 Fiscal 2021

Other expense, net in Q2 Fiscal 2022 of $188,822 primarily includes interest expense related to the $5 million Credit Facility borrowings on August 31, 2021.

Other expense, net in Q2 Fiscal 2021 of $1,536,748 primarily includes interest expense of (i) $1.4 million related to the accelerated amortization expense related to the conversion of the Convertible Notes which occurred on September 14, 2020 and (ii) $111,507 on the Convertible Notes issued on January 22, 2020 as well as the commitment fee on the Credit Facility.

1H Fiscal 2022 compared to 1H Fiscal 2021

Other income, net in 1H Fiscal 2022 of $329,759 primarily includes $498,120 of a litigation settlement amount received on July 21, 2021 offset by the write-off of a related net receivable of $45,329 with the party in this litigation; partially offset by interest expense of $25,000 related to the 2% commitment fee on the undrawn portion of the $5 million Revolving Credit Facility payable quarterly through August 31, 2021 and interest expense related to the $5 million Credit Facility borrowings on August 31, 2021.

31

Other expense, net in 1H Fiscal 2021 of $2,115,503 primarily includes: interest expense of (i) a non-cash charge of $1.4 million of accelerated amortization expense related to the conversion of the Convertible Notes which occurred on September 14, 2020 and (ii) $0.5 million for the Convertible Notes issued on January 22, 2020 as well as the commitment fee on the Credit Facility; as well as an adjustment of $0.3 million related to the previously reported earned revenue fee calculation deemed immaterial to our Fiscal 2019 revenue and a non-cash modification and accelerated amortization charges of $0.2 million related to the exercise of the 2018 and 2019 Cooperman Warrants on June 5, 2020; partially offset by $0.3 million of other income.

Income tax expense

	Three Months Ended October 31,				Six Months Ended October 31,
	2021	$ Change	% Change	2020	2021	$ Change	% Change	2020
Income tax expense	$5,900	$(30,630)	(84)%	$36,530	$156,910	$122,280	353%	$34,630

Income tax expense in 1H Fiscal 2022 includes a reserve of approximately $150,000 for the estimate of the Canada foreign income tax liability which covers the 2013 through 2021 tax years during which a permanent establishment was in place in Canada. In Q1 Fiscal 2022, the Company filed multi-year Canadian T2 Corporation Income Tax Returns and related information returns under the Voluntary Disclosure Program with the Canada Revenue Agency ("CRA").

Non-GAAP Financial Measures

This discussion and analysis includes both financial measures in accordance with Generally Accepted Accounting Principles, or GAAP, as well as non-GAAP financial measures. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position or cash flows that either excludes or includes amounts that are not normally included or excluded in the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP financial measures should be viewed as supplemental to, and should not be considered as alternatives to net income (loss), operating income (loss), and cash flow from operating activities, liquidity or any other financial measures. They may not be indicative of the historical operating results of AGI nor are they intended to be predictive of potential future results. Investors should not consider non-GAAP financial measures in isolation or as substitutes for performance measures calculated in accordance with GAAP.

Our management uses and relies on EBITDA, Adjusted EBITDA, Adjusted EBITDA margin and Adjusted Gross Profit, which are non-GAAP financial measures. We believe that management, analysts and shareholders benefit from referring to the following non-GAAP financial measures to evaluate and assess our core operating results from period-to-period after removing the impact of items that affect comparability. Our management recognizes that the non-GAAP financial measures have inherent limitations because of the excluded items described below.

We have included a reconciliation of our non-GAAP financial measures to the most comparable financial measures calculated in accordance with GAAP. We believe that providing the non-GAAP financial measures, together with the reconciliation to GAAP, helps investors make comparisons between AGI and other companies. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to the specific definition being used and to the reconciliation between such measure and the corresponding GAAP measure provided by each company under applicable SEC rules.

EBITDA and Adjusted EBITDA

AGI defines Adjusted EBITDA as EBITDA excluding: (1) bad debt expense; (2) stock-based compensation; and (3) non-recurring charges or gains. The following table presents a reconciliation of net loss to EBITDA and Adjusted EBITDA and of net loss margin to the Adjusted EBITDA margin:

32

	Three Months Ended October 31,				Six Months Ended October 31,
	2021		2020		2021		2020
Net loss	$	(2,852,258)	$	(4,370,525)	$	(3,723,146)	$	(5,313,721)
Interest expense, net	138,064		1,529,517		170,196		1,984,740
Taxes	5,900		36,530		156,910		34,630
Depreciation and amortization	817,234		526,357		1,596,643		1,016,981
EBITDA	(1,891,060)		(2,278,121)		(1,799,397)		(2,277,370)
Bad debt expense	350,000		632,000		700,000		1,032,000
Stock-based compensation	722,158		1,831,548		1,264,870		2,318,658
Non-recurring charges - Severance	—		—		19,665		44,000
Non-recurring (income) charges - Other	103,754		—		(394,366)		375,437
Adjusted EBITDA	$	(715,148)	$	185,427	$	(209,228)	$	1,492,725
Net loss Margin	(15)%		(26)%		(10)%		(17)%
Adjusted EBITDA Margin	(4)%		1%		(1)%		5%

In 1H Fiscal 2022, non-recurring income of $394,366 primarily includes $498,120 of a litigation settlement amount received on July 21, 2021 offset by the write-off of a related net receivable of $45,329 with the party in this litigation, which is included in "other (expense) income, net."

In 1H Fiscal 2021, stock based compensation expense of $1.2 million related to the accelerated amortization expense for the price vesting of Executive RSUs in Q2 Fiscal 2021 and $375,437 of non-recurring charges in Q1 Fiscal 2021. EBITDA in Q2 Fiscal 2021 includes $1.4 million related to the accelerated amortization expense of the original issue discount for the automatic conversion of $10 million Convertible Notes on September 14, 2020 (included in "Interest expense, net"). An additional non-recurring item in Q1 Fiscal 2021 of $123,947 (included in "Interest expense, net"), which arose from the acceleration of amortization arising from the exercise of warrants issued to a lender.

The following tables present a reconciliation of net loss to EBITDA and Adjusted EBITDA and of net loss margin to the Adjusted EBITDA margin by subsidiary:

Q2 Fiscal 2022 compared to Q2 Fiscal 2021

	Three Months Ended October 31, 2021
	Consolidated		AGI Corporate		AU		USU
Net income (loss)	$	(2,852,258)	$	(5,059,164)	$	1,329,813	$	877,093
Interest expense, net	138,064		139,239		(739)		(436)
Taxes	5,900		1,249		3,400		1,251
Depreciation and amortization	817,234		38,141		681,107		97,986
EBITDA	(1,891,060)		(4,880,535)		2,013,581		975,894
Bad debt expense	350,000		—		250,000		100,000
Stock-based compensation	722,158		672,967		23,298		25,893
Non-recurring charges - Severance	—		—		—		—
Non-recurring income - Other	103,754		58,325		45,429		—
Adjusted EBITDA	$	(715,148)	$	(4,149,243)	$	2,332,308	$	1,101,787
Net income (loss) Margin	(15)%		NM		10%		14%
Adjusted EBITDA Margin	(4)%		NM		18%		18%

________________________________

NM - Not meaningful

33

	Three Months Ended October 31, 2020
	Consolidated		AGI Corporate		AU		USU
Net income (loss)	$	(4,370,525)	$	(7,136,251)	$	2,207,770	$	557,956
Interest expense, net	1,529,517		1,529,519		—		(2)
Taxes	36,530		12,550		23,780		200
Depreciation and amortization	526,357		13,391		481,673		31,293
EBITDA	(2,278,121)		(5,580,791)		2,713,223		589,447
Bad debt expense	632,000		—		572,000		60,000
Stock-based compensation	1,831,548		1,684,400		86,317		60,831
Non-recurring charges - Severance	—		—		—		—
Non-recurring charges - Other	—		—		—		—
Adjusted EBITDA	$	185,427	$	(3,896,391)	$	3,371,540	$	710,278
Net income (loss) Margin	(26)%		NM		18%		11%
Adjusted EBITDA Margin	1%		NM		28%		14%

Adjusted EBITDA margin decreased to (4)% in Q2 Fiscal 2022 from 1% in Q2 Fiscal 2021, due primarily to an increase in an increase in faculty compensation costs related to the faculty hiring in the BSN Pre-Licensure campus locations in Phoenix, Austin and Tampa, and increases in books and other educational materials and facilities costs related to the opening of new campus locations. Additionally, our strategic shift in marketing spend and the impact of COVID-19 impacted enrollments in our AU Online business unit, which contributed to the decrease in Adjusted EBITDA margin.

1H Fiscal 2022 compared to 1H Fiscal 2021

	Six Months Ended October 31, 2021
	Consolidated		AGI Corporate		AU		USU
Net income (loss)	$	(3,723,146)	$	(9,517,700)	$	3,664,270	$	2,130,284
Interest expense, net	170,196		172,511		(1,739)		(576)
Taxes	156,910		2,412		153,207		1,291
Depreciation and amortization	1,596,643		69,184		1,344,800		182,659
EBITDA	(1,799,397)		(9,273,593)		5,160,538		2,313,658
Bad debt expense	700,000		—		500,000		200,000
Stock-based compensation	1,264,870		1,116,246		92,893		55,731
Non-recurring charges - Severance	19,665		—		—		19,665
Non-recurring income - Other	(394,366)		58,325		(452,691)		—
Adjusted EBITDA	$	(209,228)	$	(8,099,022)	$	5,300,740	$	2,589,054
Net income (loss) Margin	(10)%		NM		14%		17%
Adjusted EBITDA Margin	(1)%		NM		20%		21%

34

	Six Months Ended October 31, 2020
	Consolidated		AGI Corporate		AU		USU
Net income (loss)	$	(5,313,721)	$	(11,391,986)	$	4,517,533	$	1,560,732
Interest expense, net	1,984,740		1,984,742		—		(2)
Taxes	34,630		10,650		23,780		200
Depreciation and amortization	1,016,981		26,483		931,727		58,771
EBITDA	(2,277,370)		(9,370,111)		5,473,040		1,619,701
Bad debt expense	1,032,000		—		912,000		120,000
Stock-based compensation	2,318,658		2,076,443		147,634		94,581
Non-recurring charges - Severance	44,000		44,000		—		—
Non-recurring charges - Other	375,437		375,437		—		—
Adjusted EBITDA	$	1,492,725	$	(6,874,231)	$	6,532,674	$	1,834,282
Net income (loss) Margin	(17)%		NM		20%		17%
Adjusted EBITDA Margin	5%		NM		29%		20%

Adjusted EBITDA margin decreased to (1)% in 1H Fiscal 2022 from 5% in 1H Fiscal 2021, due primarily to the factors described above in the three months discussion.

Adjusted Gross Profit

GAAP Gross Profit is revenue less cost of revenue less amortization expense. The Company defines Adjusted Gross Profit as GAAP Gross Profit adjusted to exclude amortization expense. The following table presents a reconciliation of GAAP Gross Profit to Adjusted Gross Profit:

	Three Months Ended October 31,				Six Months Ended October 31,
	2021		2020		2021	2020
Revenue	$	18,940,211	$	16,971,045	$38,371,206	$32,136,607
Cost of Revenue	8,789,201		7,324,780		17,382,769	13,172,303
Adjusted Gross Profit	10,151,010		9,646,265		20,988,437	18,964,304
Less amortization expense included in cost of revenue:
Intangible asset amortization	27,496		10,516		37,988	22,463
Call center software/website amortization	432,392		346,653		836,143	661,760
Total amortization expense included in cost of revenue	459,888		357,169		874,131	684,223
GAAP Gross Profit	$	9,691,122	$	9,289,096	$20,114,306	$18,280,081
GAAP Gross Profit as a percentage of revenue	51%		55%		52%	57%
Adjusted Gross Profit as a percentage of revenue	54%		57%		55%	59%

Q2 Fiscal 2022 compared to Q2 Fiscal 2021

Adjusted gross profit as a percentage of revenue decreased due primarily to a more than anticipated decrease in class starts year-over-year in the pre-licensure program due to the effects of the COVID surge and additional full-time faculty staffing in the USU MSN-FNP program and faculty hiring in the BSN Pre-Licensure campus locations in Phoenix, Austin, Tampa and Nashville; and planned advertising spending increase throughout Fiscal Year 2022, targeted primarily to our highest LTV programs. The majority of the advertising spending increase is directed to the new pre-licensure metro locations: Austin, Nashville and Tampa, as well as USU's MSN-FNP program.

Aspen University GAAP Gross Profit represented 50% of Aspen University revenue for Q2 Fiscal Year 2022, and USU GAAP Gross Profit represented 58% of USU revenue for Q2 Fiscal Year 2022.

1H Fiscal 2022 compared to 1H Fiscal 2021

35

Adjusted gross profit as a percentage of revenue decreased due primarily to the factors described above in the three months discussion.

Aspen University GAAP Gross Profit represented 52% of Aspen University revenue for 1H Fiscal Year 2022, and USU GAAP Gross Profit represented 59% of USU revenue for 1H Fiscal Year 2022.

Liquidity and Capital Resources

Long-term Debt

For a detailed description of long-term debt, see “Note 6—Long-term Debt” to the consolidated financial statements included in “Item 1. Consolidated Financial Statements.”

Cash flow information

A summary of the Company's cash flows is as follows:

	Six Months Ended October 31,
	2021		2020
Net cash (used in) provided by
Operating activities	$	(3,453,933)	$	(2,076,821)
Investing activities	(2,849,652)		(2,244,723)
Financing activities	5,056,034		3,297,107
Net decrease in cash	$	(1,247,551)	$	(1,024,437)

Net Cash Used in Operating Activities

Net cash used in operating activities for the six months ended October 31, 2021 consists of net loss adjusted for non-cash items and the effect of changes in working capital. Non-cash adjustments primarily include stock-based compensation, bad debt expense, depreciation and amortization expense, amortization of debt issue costs and deferred financing costs, warrants issued for services and other adjustments such as tenant improvement allowances received from landlords.

Adjustments to net loss consist primarily of depreciation and amortization expense of $1,596,643, stock-based compensation of $1,264,870, bad debt expense of $700,000, tenant improvement allowances received from landlords of $816,591, amortization of warrant based cost of $27,583, amortization of deferred financing costs of $19,643 and debt issue costs of $18,056. The increase from changes in working capital primarily consists of increases in gross accounts receivable (both short and long term accounts receivable, before allowance for doubtful accounts) of $7,699,220, prepaid expenses of $520,685 and a decrease in accrued expenses of $268,088, partially offset by increases in deferred revenue of $3.4 million, accounts payable of $636,136 and due to students of $472,159. The increase in accounts receivable is primarily attributed to the growth in revenue from increased enrollments and students paying through the monthly payment plan as well as timing of billings for class starts. The increase in deferred revenue is due primarily to timing of billings for class starts and higher revenue.

The Company expects a favorable trend in working capital over time, but there may be volatility from quarter to quarter. In aggregate the Company expects a general trend toward lower cash used in operations in future quarters; however, some quarters could have higher cash used in operations as a result of more cash used to support changes in working capital. Program start timings and the related federal financial aid drawdowns also impact cash timing.

Net cash used in operations for the six months ended October 31, 2020 consist primarily of stock-based compensation of $2,318,658, amortization of debt discounts of $1,550,854, bad debt expense of $1,032,000 and depreciation and amortization expense of $1,016,981. The increase from changes in working capital primarily consists of an increase in gross accounts receivable (both short and long term accounts receivable, before allowance for doubtful accounts) of $8,246,180, partially offset by an increase in deferred revenue of $4,915,504 and accrued expenses of $1,282,983. The increase in accounts receivable is primarily attributed to the growth in revenues from increased enrollments and students paying through the monthly payment plan as well as timing of billings for class start near the end of Q2 Fiscal 2021. The increase in deferred revenue is due primarily to timing of billings for class start near the end of Q2 Fiscal 2021 and higher revenue. The increase in accrued expenses is due primarily to accrual of executive bonus for Fiscal 2021, accrued payroll due to higher headcount and related

36

increase in compensation and benefits expense to support the growth of the business and an increase in accrued marketing due to timing.

Net Cash Used in Investing Activities

Net cash used in investing activities for the six months ended October 31, 2021 includes purchases of property and equipment of $2.7 million primarily due to investments in leasehold improvements, computer equipment and hardware and Company developed software. Purchases of courseware and accreditation were $0.1 million. A significant portion cash used for investing activities relates to the opening of new campus locations.

Net cash used in investing activities for the six months ended October 31, 2020 includes purchases of property and equipment of $2,233,348 primarily due to investments in computer equipment and hardware, Company developed software and new campuses; and purchases of courseware and accreditation of $11,375.

Net Cash Provided By Financing Activities

Net cash provided by financing activities for the six months ended October 31, 2021 includes proceeds of $5,000,000 from borrowings under the Credit Facility and proceeds from stock options exercised of $56,034.

Net cash provided by financing activities for the six months ended October 31, 2020 includes proceeds from stock options exercised of $2,215,315 and proceeds from warrants exercised of $1,081,792 received from the cash exercise of warrants associated with the Term Loan and Revolving Credit Facility.

Liquidity and Capital Resources

Our cash balances are kept liquid to support our growing infrastructure needs. The majority of our cash is concentrated in large financial institutions.

On August 31, 2021, the Company extended the Revolving Credit Facility by one year to November 4, 2022. The Credit Facility Agreement provides for a $5,000,000 revolving credit facility evidenced by a revolving promissory note. Borrowings under the Credit Facility Agreement bear interest at 12% per annum. In conjunction with the extension of the Revolving Credit Facility, the Company drew down $5,000,000 of funds from the Revolving Credit Facility at 12% interest per annum due November 4, 2022. Pursuant to this agreement, on August 31, 2021 the Company issued to the Foundation warrants to purchase 50,000 shares of the Company’s common stock exercisable for five years from the date of issuance at the exercise price of $5.89 per share. The Company expects to use these funds for general business purposes, including the roll out of the new campuses. The Company anticipates that the Aspen 2.0 business plan, with lower advertising budget that targets the highest LTV programs, will reduce the need to borrow funds in the future.

At October 31, 2021 and April 30, 2021, there were $5,000,000 and no outstanding borrowings, respectively, under the Credit Facility.

The Company anticipates that it will need to make capital and other expenditures in connection with the development and expansion of its campus operations. The Company's Fiscal year 2022 capital expenditures are expected to be lower than Fiscal Year 2021 capital expenditures by approximately $0.5 million related to new campus costs. Additionally, the Company expects additional cash commitments for letters of credit related to securing new campus locations.

The Company expects that its existing cash resources will be sufficient to fund its working capital, including capital expenditures, investing and other needs for the next 12 months.

Critical Accounting Policies and Estimates

At October 31, 2021, there were no material changes to our critical accounting policies and estimates. A full listing of our critical accounting policies and estimates is described in the "Critical Accounting Policies and Estimates" of our Annual Report on Form 10-K for the fiscal year ended April 30, 2021 and listed here below:

•Revenue Recognition and Deferred Revenue

•Accounts Receivable and Allowance for Doubtful Accounts Receivable

•Goodwill and Intangibles

•Stock-based compensation

37

Off Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements as of October 31, 2021.

Cautionary Note Regarding Forward Looking Statements

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding our goal of achieving positive GAAP net income by Q4 of the fiscal year 2022, our focusing of advertising spend on the highest LTV units, the anticipated impact of this plan on our future operating results, liquidity and growth, the expected growth in our highest efficiency businesses, our estimates concerning LTV, bookings and ARPU, our expectations regarding accounts receivable, the expected continued revenue growth in Aspen University’s BSN Pre-Licensure and USU’s MSN-FNP programs, the impact of COVID-19 on class starts and enrollments, our anticipated working capital trends, the intended use of proceeds from the drawdown under the revolving credit facility, our expected capital expenditures related to new campus openings and letters of credit and our liquidity. All statements other than statements of historical facts contained in this report, including statements regarding our future financial position, liquidity, business strategy and plans and objectives of management for future operations, are forward-looking statements. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs.

The results anticipated by any or all of these forward-looking statements might not occur. Important factors, uncertainties and risks that may cause actual results to differ materially from these forward-looking statements include, without limitation, our ability to successfully implement the fiscal year 2022 business plan and the accuracy of the assumptions used in estimating the results of such implementation, the continued high demand for nurses, the continued effectiveness of our marketing efforts, the effectiveness of our collection efforts and process improvements, our ability to obtain the necessary regulatory approvals to launch our future campuses in a timely fashion or at all, national and local economic factors including the substantial impact of the COVID-19 on nurses and the economy, competition from nursing schools in local markets, the competitive impact from the trend of major non-profit universities using online education, unfavorable regulatory changes, rising acquisition costs and potential loss of employees as a result of COVID-19 vaccine mandate. Further information on the risks and uncertainties affecting our business is contained in our filings with the SEC, including this Form 10-Q and our Annual Report on Form 10-K for the fiscal year ended April 30, 2021. We undertake no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events or otherwise.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Our management carried out an evaluation, with the participation of our Principal Executive Officer and Principal Financial Officer, required by Rule 13a-15 or 15d-15 of the Securities Exchange Act of 1934 (the “Exchange Act”) of the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) or 15d-15(e) under the Exchange Act. Based on their evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures are effective as of the end of the period covered by this report to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting as defined in Rule 13a-15(f) or 15d-15(f) under the Exchange Act that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

38

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time-to-time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. Other than the previously disclosed receipt of payment of $498,120 as a final distribution by the bankruptcy trustee in HEMG bankruptcy proceedings, during the period covered by this report, there were no material changes to the description of legal proceedings set forth in our Annual Report on Form 10-K for the fiscal year ended April 30, 2021.

ITEM 1A. RISK FACTORS

The information presented below updates, and should be read in conjunction with, the risk factors and information disclosed in our Annual Report on Form 10-K for the fiscal year ended April 30, 2021.

The OSHA directive concerning mandatory COVID-19 vaccination of employees could have a material adverse impact on our business and results of operations.

On September 9, 2021, President Biden announced a proposed new rule requiring all employers with at least 100 employees to ensure that their employees are fully vaccinated or require unvaccinated workers to get a negative test at least once a week. Effective November 5, 2021, the Occupational Health and Safety Administration (OSHA) issued a COVID-19 Vaccination and Testing Emergency Temporary Standard (ETS) which would require employers with 100 or more employees, by January 4, 2022, to require their workers either to be fully vaccinated (or at least have received a final dose of a primary vaccine series) or to test weekly for COVID-19. However, a federal district court has issued a nationwide preliminary injunction prohibiting the U.S. government from enforcing the ETS mandate. It is currently not possible to predict with certainty the exact impact the ETS would have on us in the event the injunction is lifted. As a company with more than 100 employees, in the event the injunction is lifted, we would be required to mandate COVID-19 vaccination of our workforce or our unvaccinated employees would require weekly testing. This may result in employee attrition, which could be material as a substantial number of our employees are based in Arizona where vaccination rates are below the national average. If we were to lose employees, it could have an adverse effect on future revenues and costs, which could be material. Accordingly, the proposed ETS when implemented could have a material adverse effect on our business and results of operations.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS  

All recent sales of unregistered securities have been previously reported.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Not applicable.

ITEM 6. EXHIBITS

See the Exhibit Index at the end of this report.

39

EXHIBIT INDEX

		Incorporated by Reference			Filed or Furnished Herewith
Exhibit #	Exhibit Description	Form	Date	Number
3.1	Certificate of Incorporation, as amended	10-K	7/9/19	3.1
3.2	Bylaws, as amended	10-Q	3/15/18	3.2
10.1	Warrant dated July 21, 2021	10-Q	9/14/21	10.1
10.2	Employment Agreement, effective August 16, 2021, by the Company and Matthew LaVay*	8-K	8/16/21	10.1
31.1	Certification of Principal Executive Officer (302)				Filed
31.2	Certification of Principal Financial Officer (302)				Filed
32.1	Certification of Principal Executive and Principal Financial Officer (906)				Furnished**
101.INS	Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH	Inline XBRL Taxonomy Extension Schema Document				Filed
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document				Filed
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document				Filed
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document				Filed
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document				Filed
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

_____________________

*    Management contract or compensatory plan or arrangement.

**    This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.

Copies of this report (including the financial statements) and any of the exhibits referred to above will be furnished at no cost to our shareholders who make a written request to Aspen Group, Inc., at the address on the cover page of this report, Attention: Corporate Secretary.

40

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Aspen Group, Inc.
December 14, 2021	By:	/s/ Michael Mathews
		Michael Mathews Chief Executive Officer (Principal Executive Officer)

December 14, 2021	By:	/s/ Matthew LaVay
		Matthew LaVay Chief Financial Officer (Principal Financial Officer)

December 14, 2021	By:	/s/ Robert Alessi
		Robert Alessi Chief Accounting Officer (Principal Accounting Officer)

41

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Michael Mathews, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Aspen Group, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: December 14, 2021

/s/ Michael Mathews

Michael Mathews
Chief Executive Officer
(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

I, Matthew LaVay, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Aspen Group, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: December 14, 2021

/s/ Matthew LaVay

Matthew LaVay
Chief Financial Officer
(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Aspen Group, Inc. (the “Company”) on Form 10-Q for the quarter ended October 31, 2021, as filed with the Securities and Exchange Commission on the date hereof, I, Michael Mathews, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1.The quarterly report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

2.The information contained in the quarterly report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Michael Mathews

Michael Mathews
Chief Executive Officer
(Principal Executive Officer)

Dated: December 14, 2021

In connection with the quarterly report of Aspen Group, Inc. (the “Company”) on Form 10-Q for the quarter ended October 31, 2021, as filed with the Securities and Exchange Commission on the date hereof, I, Matthew LaVay, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1.The quarterly report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

2.The information contained in the quarterly report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Matthew LaVay

Matthew LaVay
Chief Financial Officer
(Principal Financial Officer)

Dated: December 14, 2021

XML

COVER PAGE - shares	6 Months Ended
	Oct. 31, 2021	Dec. 10, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2021
Document Transition Report	false
Entity File Number	001-38175
Entity Registrant Name	ASPEN GROUP, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-1933597
Entity Address, Address Line One	276 Fifth Avenue
Entity Address, Address Line Two	Suite 505
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10001
City Area Code	646
Local Phone Number	448-5144
Title of 12(b) Security	Common Stock, par value $0.001
Trading Symbol	ASPU
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		25,034,375
Amendment Flag	false
Current Fiscal Year End Date	--04-30
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Entity Central Index Key	0001487198

XML

CONSOLIDATED BALANCE SHEETS - USD ($)	Oct. 31, 2021	Apr. 30, 2021
Current assets:
Cash and cash equivalents	$ 10,985,131	$ 12,472,082
Restricted cash	1,433,397	1,193,997
Accounts receivable, net of allowance of $3,345,182 and $3,289,816, respectively	21,309,982	16,724,744
Prepaid expenses	1,577,516	1,077,831
Other current assets	20,631	68,529
Total current assets	35,326,657	31,537,183
Property and equipment:
Property and equipment, gross	20,432,353	17,548,329
Less: accumulated depreciation and amortization	(6,672,208)	(4,892,987)
Total property and equipment, net	13,760,145	12,655,342
Goodwill	5,011,432	5,011,432
Accounts receivable, net of allowance of $— and $625,963, respectively	0	45,329
Long-term contractual accounts receivable	12,663,815	10,249,833
Deferred financing costs	117,857	18,056
Operating lease right of use assets, net	13,510,656	12,714,863
Deposits and other assets	515,569	479,212
Total assets	89,113,548	80,806,906
Current liabilities:
Accounts payable	2,102,624	1,466,488
Accrued expenses	1,772,808	2,040,896
Deferred revenue	10,191,241	6,825,014
Due to students	3,219,643	2,747,484
Operating lease obligations, current portion	2,145,431	2,029,821
Other current liabilities	96,003	307,921
Total current liabilities	19,527,750	15,417,624
Long-term debt	5,000,000	0
Operating lease obligations, less current portion	17,732,483	16,298,808
Total liabilities	42,260,233	31,716,432
Commitments and contingencies – see Note 11
Stockholders' equity:
Preferred stock, $0.001 par value; 1,000,000 shares authorized, 0 issued and 0 outstanding at October 31, 2021 and April 30, 2021	0	0
Common stock, $0.001 par value; 40,000,000 shares authorized, 25,148,194 issued and 24,992,708 outstanding at October 31, 2021; 25,066,297 issued and 24,910,811 outstanding at April 30, 2021	25,149	25,067
Additional paid-in capital	110,526,729	109,040,824
Treasury stock (155,486 at both October 31, 2021 and April 30, 2021)	(1,817,414)	(1,817,414)
Accumulated deficit	(61,881,149)	(58,158,003)
Total stockholders’ equity	46,853,315	49,090,474
Total liabilities and stockholders’ equity	89,113,548	80,806,906
Computer equipment and hardware
Property and equipment:
Property and equipment, gross	1,402,006	956,463
Furniture and fixtures
Property and equipment:
Property and equipment, gross	1,976,342	1,705,101
Leasehold improvements
Property and equipment:
Property and equipment, gross	7,057,859	5,729,324
Instructional equipment
Property and equipment:
Property and equipment, gross	608,894	421,039
Software
Property and equipment:
Property and equipment, gross	9,386,352	8,488,635
Intangible assets, net	5,102,223	5,044,310
Construction in progress
Property and equipment:
Property and equipment, gross	900	247,767
Intangible assets, net
Property and equipment:
Intangible assets, net	7,907,503	7,908,360
Courseware, net
Property and equipment:
Intangible assets, net	$ 299,914	$ 187,296

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Oct. 31, 2021	Apr. 30, 2021
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$ 3,345,182	$ 3,289,816
Accounts receivable, secured, allowance	$ 0	$ 625,963
Preferred stock par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock issued (in shares)	0	0
Preferred stock outstanding (in shares)	0	0
Common stock par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	40,000,000	40,000,000
Common stock issued (in shares)	25,148,194	25,066,297
Common stock outstanding (in shares)	24,992,708	24,910,811
Treasury stock (in shares)	155,486	155,486

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Income Statement [Abstract]
Revenue	$ 18,940,211	$ 16,971,045	$ 38,371,206	$ 32,136,607
Operating expenses:
Cost of revenue (exclusive of depreciation and amortization shown separately below)	8,789,201	7,324,780	17,382,769	13,172,303
General and administrative	11,641,312	11,285,155	22,587,789	20,078,911
Bad debt expense	350,000	632,000	700,000	1,032,000
Depreciation and amortization	817,234	526,357	1,596,643	1,016,981
Total operating expenses	21,597,747	19,768,292	42,267,201	35,300,195
Operating loss	(2,657,536)	(2,797,247)	(3,895,995)	(3,163,588)
Other income (expense):
Interest expense	(139,502)	(1,529,668)	(173,041)	(1,985,125)
Other (expense) income, net	(49,320)	(7,080)	502,800	(130,378)
Total other (expense) income, net	(188,822)	(1,536,748)	329,759	(2,115,503)
Loss before income taxes	(2,846,358)	(4,333,995)	(3,566,236)	(5,279,091)
Income tax expense	5,900	36,530	156,910	34,630
Net loss	$ (2,852,258)	$ (4,370,525)	$ (3,723,146)	$ (5,313,721)
Net loss per share - basic (in dollars per share)	$ (0.11)	$ (0.19)	$ (0.15)	$ (0.23)
Net loss per share - diluted (in dollars per share)	$ (0.11)	$ (0.19)	$ (0.15)	$ (0.23)
Weighted average number of common stock outstanding - basic (in shares)	24,957,046	22,791,503	24,935,793	22,763,235
Weighted average number of common stock outstanding - diluted (in shares)	24,957,046	22,791,503	24,935,793	22,763,235

XML

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Total	Common Stock	Additional Paid-In Capital	Treasury Stock	Accumulated Deficit
Beginning balance at Apr. 30, 2020	$ 41,747,957	$ 21,771	$ 89,505,216	$ (70,000)	$ (47,709,030)
Beginning balance (in shares) at Apr. 30, 2020		21,770,520
Ending balance at Jul. 31, 2020	43,678,736	$ 22,378	92,378,584	(70,000)	(48,652,226)
Ending balance (in shares) at Jul. 31, 2020		22,377,744
Beginning balance at Apr. 30, 2020	41,747,957	$ 21,771	89,505,216	(70,000)	(47,709,030)
Beginning balance (in shares) at Apr. 30, 2020		21,770,520
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	2,318,658		2,318,658
Common stock issued for stock options exercised for cash	2,215,315	$ 918	2,214,397
Common stock issued for stock options exercised for cash (in shares)		917,587
Common stock issued for cashless stock options exercised	0	$ 22	(22)
Common stock issued for cashless stock options exercised (in shares)		22,339
Common stock issued for conversion of Convertible Notes	10,000,000	$ 1,399	9,998,601
Common stock issued for conversion of Convertible Notes (in shares)		1,398,602
Common stock issued for vested restricted stock units	0	$ 132	(132)
Common stock issued for vested restricted stock units (in shares)		132,109
Common stock issued for warrants exercised for cash	1,081,791	$ 191	1,081,600
Common stock issued for warrants exercised for cash (in shares)		192,049
Modification charge for warrants exercised	25,966		25,966
Amortization of warrant based cost	18,250		18,250
Cancellation of Treasury Stock	0	$ (17)	(69,983)	70,000
Cancellation of Treasury Stock (in shares)		(16,667)
Net loss	(5,313,721)				(5,313,721)
Ending balance at Oct. 31, 2020	52,094,216	$ 24,416	105,092,551	0	(53,022,751)
Ending balance (in shares) at Oct. 31, 2020		24,416,539
Beginning balance at Jul. 31, 2020	43,678,736	$ 22,378	92,378,584	(70,000)	(48,652,226)
Beginning balance (in shares) at Jul. 31, 2020		22,377,744
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	1,831,548		1,831,548
Common stock issued for stock options exercised for cash	945,332	$ 502	944,830
Common stock issued for stock options exercised for cash (in shares)		502,412
Common stock issued for cashless stock options exercised	0	$ 22	(22)
Common stock issued for cashless stock options exercised (in shares)		22,339
Common stock issued for conversion of Convertible Notes	10,000,000	$ 1,399	9,998,601
Common stock issued for conversion of Convertible Notes (in shares)		1,398,602
Common stock issued for vested restricted stock units	0	$ 132	(132)
Common stock issued for vested restricted stock units (in shares)		132,109
Amortization of warrant based cost	9,125		9,125
Cancellation of Treasury Stock	0	$ (17)	(69,983)	70,000
Cancellation of Treasury Stock (in shares)		(16,667)
Net loss	(4,370,525)				(4,370,525)
Ending balance at Oct. 31, 2020	52,094,216	$ 24,416	105,092,551	0	(53,022,751)
Ending balance (in shares) at Oct. 31, 2020		24,416,539
Beginning balance at Apr. 30, 2021	49,090,474	$ 25,067	109,040,824	(1,817,414)	(58,158,003)
Beginning balance (in shares) at Apr. 30, 2021		25,066,297
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	1,264,870		1,264,870
Common stock issued for stock options exercised for cash	56,034	$ 17	56,017
Common stock issued for stock options exercised for cash (in shares)		16,752
Common stock issued for cashless stock options exercised	0	$ 30	(30)
Common stock issued for cashless stock options exercised (in shares)		30,156
Common stock issued for vested restricted stock units	0	$ 35	(35)
Common stock issued for vested restricted stock units (in shares)		34,989
Amortization of warrant based cost	27,583		27,583
Warrants issued for deferred financing costs related to Credit Facility	137,500		137,500
Net loss	(3,723,146)				(3,723,146)
Ending balance at Oct. 31, 2021	46,853,315	$ 25,149	110,526,729	(1,817,414)	(61,881,149)
Ending balance (in shares) at Oct. 31, 2021		25,148,194
Beginning balance at Jul. 31, 2021	48,796,304	$ 25,088	109,617,521	(1,817,414)	(59,028,891)
Beginning balance (in shares) at Jul. 31, 2021		25,087,051
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	722,158		722,158
Common stock issued for stock options exercised for cash	33,486	$ 12	33,474
Common stock issued for stock options exercised for cash (in shares)		11,655
Common stock issued for cashless stock options exercised	0	$ 30	(30)
Common stock issued for cashless stock options exercised (in shares)		30,156
Common stock issued for vested restricted stock units	0	$ 19	(19)
Common stock issued for vested restricted stock units (in shares)		19,332
Amortization of warrant based cost	16,125		16,125
Warrants issued for deferred financing costs related to Credit Facility	137,500		137,500
Net loss	(2,852,258)				(2,852,258)
Ending balance at Oct. 31, 2021	$ 46,853,315	$ 25,149	$ 110,526,729	$ (1,817,414)	$ (61,881,149)
Ending balance (in shares) at Oct. 31, 2021		25,148,194

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Cash flows from operating activities:
Net loss	$ (3,723,146)	$ (5,313,721)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense	700,000	1,032,000
Depreciation and amortization	1,596,643	1,016,981
Stock-based compensation	1,264,870	2,318,658
Amortization of warrant based cost	27,583	18,250
Amortization of debt discounts	0	1,550,854
Amortization of debt issue costs	18,056	147,695
Amortization of deferred financing costs	19,643	0
Modification charge for warrants exercised	0	25,966
Loss on asset disposition	36,442	0
Lease benefit	(63,099)	0
Tenant improvement allowances received from landlords	816,591	0
Changes in operating assets and liabilities:
Accounts receivable	(7,699,220)	(8,246,180)
Prepaid expenses	(520,685)	(654,268)
Other receivables	0	23,097
Other current assets	47,901	(273,767)
Accounts receivable, other	45,329	0
Deposits and other assets	(15,357)	(171,303)
Accounts payable	636,136	838,421
Accrued expenses	(268,088)	1,282,983
Due to students	472,159	(301,619)
Deferred revenue	3,366,227	4,915,504
Other current liabilities	(211,918)	(286,372)
Net cash used in operating activities	(3,453,933)	(2,076,821)
Cash flows from investing activities:
Purchases of courseware and accreditation	(149,751)	(11,375)
Purchases of property and equipment	(2,699,901)	(2,233,348)
Net cash used in investing activities	(2,849,652)	(2,244,723)
Cash flows from financing activities:
Borrowings under the Credit Facility	5,000,000	0
Proceeds from stock options exercised	56,034	2,215,315
Proceeds from warrants exercised	0	1,081,792
Net cash provided by financing activities	5,056,034	3,297,107
Net decrease in cash, cash equivalents and restricted cash	(1,247,551)	(1,024,437)
Cash, restricted cash, and cash equivalents at beginning of period	13,666,079	17,906,765
Cash, restricted cash, and cash equivalents at end of period	12,418,528	16,882,328
Supplemental disclosure cash flow information:
Cash paid for interest	98,904	285,749
Cash paid for income taxes	157,552	38,608
Supplemental disclosure of non-cash investing and financing activities:
Common stock issued for conversion of Convertible Notes	0	10,000,000
Warrants issued as part of Credit Facility	$ 137,500	$ 0

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)	Oct. 31, 2021	Apr. 30, 2021	Oct. 31, 2020	Apr. 30, 2020
Statement of Cash Flows [Abstract]
Cash and cash equivalents	$ 10,985,131	$ 12,472,082
Restricted cash	1,433,397	1,193,997
Total cash, cash equivalents and restricted cash	$ 12,418,528	$ 13,666,079	$ 16,882,328	$ 17,906,765

XML

Nature of Operations

6 Months Ended

Oct. 31, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Operations

Nature of Operations

Overview

Aspen Group, Inc. ("AGI") is an education technology holding company. AGI has two subsidiaries, Aspen University Inc. ("Aspen University"), organized in 1987, and United States University Inc. ("United States University" or "USU").

All references to the “Company”, “AGI”, “Aspen Group”, “we”, “our” and “us” refer to Aspen Group, Inc., unless the context otherwise indicates.

AGI leverages its education technology infrastructure and expertise to allow its two universities, Aspen University and United States University, to deliver on the vision of making college affordable again. Because we believe higher education should be a catalyst to our students’ long-term economic success, we exert financial prudence by offering affordable tuition that is one of the greatest values in higher education.  AGI’s primary focus relative to future growth is to target the high growth nursing profession.

Since 1993, Aspen University has been nationally accredited by the Distance Education Accrediting Council (“DEAC”), an institutional accrediting agency recognized by the United States Department of Education (the “DOE”), through January 2024.

Since 2009, USU has been institutionally accredited by WASC Senior College and University Commission. (“WSCUC”).

Both universities are qualified to participate under the Higher Education Act of 1965, as amended (HEA) and the Federal student financial assistance programs (Title IV, HEA programs). USU has a provisional certification resulting from the ownership change of control in connection with the acquisition by AGI on December 1, 2017.

COVID-19 Update

Nursing students represented 87% or 12,442 of the Company’s total student body of 14,318 students at the end of the second quarter of fiscal 2022. Of the 12,442 nursing students, 2,500 are BSN Pre-Licensure students located across our four metro locations (Phoenix, Austin, Tampa and Nashville). The remaining 9,942 nursing students are licensed registered nurses (RNs) studying to earn an advanced degree (RN to BSN, MSN, MSN-FNP or DNP degree programs). Therefore, these 9,942 post-licensure nursing students represent 69% of the Company’s total student body and are the population of AGI students primarily affected by the COVID-19 pandemic.

Starting in the second half of June 2021 and continuing through October 2021, the Company saw lower course starts than seasonally expected among our RN student body. For example, at Aspen University, course starts among RNs from June through October increased by approximately 3% year-over-year. By comparison, over the previous two full fiscal years (Fiscal Year 2021 and Fiscal Year 2020), course starts among RNs at Aspen University increased by an average of approximately 10% year-over-year.

In terms of new student enrollments, the Company saw enrollment growth on a quarterly sequential basis in all BSN Pre-Licensure metros as these prospective students continue to communicate a strong desire to enter the nursing profession. However, aggregate enrollments among RNs at both Aspen University and United States University were relatively flat on a quarterly sequential basis.

We cannot be certain what impact the Delta variant and other variants will have on the Company’s results as we progress through the second half of fiscal 2022.

Basis of Presentation

Interim Financial Statements

The interim consolidated financial statements included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring adjustments) necessary to present fairly our results of operations for the three and six months ended October 31, 2021 and 2020, our cash flows for the six months ended October 31, 2021 and 2020, and our financial position as of October 31, 2021 have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year.

Certain information and disclosures normally included in the notes to the annual consolidated financial statements have been condensed or omitted from these interim consolidated financial statements. Accordingly, these interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended April 30, 2021 as filed with the SEC on July 13, 2021. The April 30, 2021 consolidated balance sheet is derived from those statements.

XML

Significant Accounting Policies

6 Months Ended

Oct. 31, 2021

Accounting Policies [Abstract]

Significant Accounting Policies

Significant Accounting Policies

Basis of Presentation and Consolidation

The Company prepares its consolidated financial statements in accordance with U.S. generally accepted accounting principles ("GAAP").

The consolidated financial statements include the accounts of AGI and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

A full listing of our significant accounting policies is described in Note 2 “Summary of Significant Accounting Policies” of our Annual Report on Form 10-K for the fiscal year ended April 30, 2021 as filed with the SEC on July 13, 2021.

Accounting Estimates

Management of the Company is required to make certain estimates, judgments and assumptions during the preparation of its consolidated financial statements in accordance with GAAP. These estimates, judgments and assumptions impact the reported amounts of assets, liabilities, revenue and expenses and the related disclosure of contingent assets and liabilities. Actual results could differ from those estimates.

Significant estimates in the accompanying consolidated financial statements include the allowance for doubtful accounts and other receivables, the valuation of lease liabilities and the carrying value of the related right-of-use ("ROU") assets, depreciable lives of property and equipment, amortization periods and valuation of courseware, intangibles and software development costs, valuation of goodwill, valuation of loss contingencies, valuation of stock-based compensation and the valuation allowance on deferred tax assets.

Cash, Cash Equivalents, and Restricted Cash

For the purposes of the consolidated statements of cash flows, the Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.

Restricted cash as of October 31, 2021 of $1,433,397 consists of $1,173,525 which is collateral for letters of credit for the Aspen University and USU facility operating leases, $9,872 which is collateral for a letter of credit for USU required to be posted based on the level of Title IV funding in connection with USU's most recent Compliance Audit, and a $250,000 compensating balance under a secured credit line.

Restricted cash as of April 30, 2021 of $1,193,997 consisted of $934,125 which is collateral for letters of credit for the Aspen University and USU facility operating leases, $9,872 which is collateral for a letter of credit for USU required to be posted based on the level of Title IV funding in connection with USU's most recent Compliance Audit, and a $250,000 compensating balance under a secured credit line.

Concentration of Credit Risk

The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits of $250,000 per financial institution. The Company has not experienced any losses in such accounts from inception through October 31, 2021. As of October 31, 2021 and April 30, 2021, the Company maintained deposits exceeding federally insured limits by approximately $11,765,690 and $13,005,537, respectively, held in two separate institutions.

Revenue Recognition and Deferred Revenue

The Company follows Accounting Standards Codification 606 (ASC 606). ASC 606 is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASC also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer purchase orders, including significant judgments.

Revenue consists primarily of tuition and course fees derived from courses taught by the Company online and in-person as well as from related educational resources and services that the Company provides to its students. Under ASC 606, tuition and course fee revenue is recognized pro-rata over the applicable period of instruction and are not considered separate performance obligations.  Non-tuition related revenue and fees are recognized as services are provided or when the goods are received by the student. (See Note 8) Students may receive discounts, scholarships, or refunds, which gives rise to variable consideration. The amounts of discounts or scholarships are applied to individual student accounts when such amounts are awarded. Therefore, the tuition is reduced directly by these discounts or scholarships from the amount of the standard tuition rate charged.

Deferred revenue represents the amount of tuition, fees, and other student payments received in excess of the portion recognized as revenue and it is included in current liabilities in the accompanying consolidated balance sheets. Other revenue may be recognized as sales occur or services are performed.

Net Loss Per Share

Net loss per share is based on the weighted average number of shares of common stock outstanding during each period. Options to purchase 992,050 and 1,214,473 shares of common stock, 899,103 and 549,972 restricted stock units ("RSUs"), warrants to purchase 449,174 and 374,174 shares of common stock, and unvested restricted stock of 8,224 and 8,224 were outstanding at October 31, 2021 and April 30, 2021, respectively.

All shares mentioned above were not included in the computation of diluted net loss per share because the effects would have been anti-dilutive. The options, warrants, RSUs and unvested restricted stock are considered to be common stock equivalents and are only included in the calculation of diluted earnings per share of common stock when their effect is dilutive.

Segment Information

The Company operates in one reportable segment as a single educational delivery operation using a core infrastructure that serves the curriculum and educational delivery needs of its online and campus students regardless of geography. The Company's chief operating decision makers, its Chief Executive Officer, Chief Operating Officer and Chief Academic Officer, manage the Company's operations as a whole.

Recent Accounting Pronouncement Not Yet Adopted

ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which significantly changes how entities will measure credit losses for most financial assets, including accounts receivable. ASU No. 2016-13 will replace today’s “incurred loss” approach with an “expected loss” model, under which companies will recognize allowances based on expected rather than incurred losses. On November 15, 2019, the FASB delayed the effective date of Topic 326 for certain small public companies and other private companies until fiscal years

beginning after December 15, 2022 for SEC filers that are eligible to be smaller reporting companies under the SEC’s definition, as well as private companies and not-for-profit entities. The Company is currently evaluating the new guidance and has not yet determined whether the adoption of the new standard will have a material impact on its consolidated financial statements or the method of adoption.

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year presentation.

The Company has concluded that based on industry practices, the preferred presentation for cash received in advance for unearned tuition and stipends should be reclassified from "restricted cash" to "cash and cash equivalents." The cash balance of $3,958,793 for funds held for students for unbilled educational services that were received from Title IV and non-Title IV programs at April 30, 2021, which was previously included in "restricted cash" in the accompanying consolidated balance sheet, was reclassified to "cash and cash equivalents" to align with the current year presentation. There is no impact to total current assets included in accompanying consolidated balance sheet at April 30, 2021. The restricted cash balance at April 30, 2021, now includes letters of credit and a compensating balance under a secured credit line of $1,193,997.

XML

Property and Equipment

6 Months Ended

Oct. 31, 2021

Property, Plant and Equipment [Abstract]

Property and Equipment

Property and Equipment

As property and equipment reach the end of their useful lives, the fully expired assets are written off against the associated accumulated depreciation and amortization.

When assets are disposed of before reaching the end of their useful lives both the recorded cost of the fixed asset and the corresponding amount of accumulated depreciation is reversed. Any remaining difference between the two is recognized as either other income or expense.

Software consisted of the following:

	October 31, 2021		April 30, 2021
Software	$	9,386,352	$	8,488,635
Accumulated amortization	(4,284,129)		(3,444,325)
Software, net	$	5,102,223	$	5,044,310

Depreciation and amortization expense for property and equipment and software is summarized below:

	Three Months Ended October 31,				Six Months Ended October 31,
	2021		2020		2021		2020
Depreciation and amortization expense:
Property and equipment, excluding software	$	367,475	$	164,204	$	718,848	$	327,774
Software	$	428,143	$	346,653	$	839,804	$	661,760

XML

Courseware and Accreditation

6 Months Ended

Oct. 31, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Courseware and Accreditation

Courseware and AccreditationAs courseware and accreditation reach the end of their useful life, they are written off against the accumulated amortization. There was no expense impact for such write-offs for the three and six months ended October 31, 2021 and 2020.

Courseware and accreditation consisted of the following:

	October 31, 2021		April 30, 2021
Courseware	$	557,973	$	408,222
Accreditation	59,350		59,350
	617,323		467,572
Accumulated amortization	(317,409)		(280,276)
Courseware and accreditation, net	$	299,914	$	187,296

Amortization expense for courseware and accreditation is summarized below:

	Three Months Ended October 31,				Six Months Ended October 31,
	2021		2020		2021		2020
Amortization expense	$	21,185	$	10,516	$	37,133	$	22,463

Amortization expense is included in "Depreciation and amortization" in the unaudited consolidated statements of operations.

XML

Secured Note and Accounts Receivable	6 Months Ended
	Oct. 31, 2021
Due from Related Parties, Unclassified [Abstract]
Secured Note and Accounts Receivable	Secured Note and Accounts ReceivableOn March 30, 2008 and December 1, 2008, Aspen University sold courseware pursuant to marketing agreements to Higher Education Management Group, Inc. (“HEMG”), which was then a related party and principal stockholder of the Company. As discussed in Note 11, the Company and Aspen University sued HEMG seeking to recover sums due under the agreements. Ultimately, the Company and Aspen University obtained a favorable default judgment, and as a result received a distribution from the bankruptcy trustee court of $498,120, which is included in "other (expense) income, net" in the accompanying unaudited consolidated statements of operations for the six months ended October 31, 2021. Due to the bankruptcy of HEMG, the Company also wrote off a net receivable of $45,329

XML

Long-term Debt

6 Months Ended

Oct. 31, 2021

Debt Disclosure [Abstract]

Long-term Debt

Long-term Debt

Credit Facility

On November 5, 2018, the Company entered into a loan agreement (the “Credit Facility Agreement”) with the Leon and Toby Cooperman Family Foundation (the “Foundation”). The Credit Facility Agreement provided for a $5,000,000 revolving credit facility (the “Credit Facility”) evidenced by a revolving promissory note (the “Revolving Note”). Borrowings under the Credit Facility Agreement bear interest at 12% per annum. Interest payments are due monthly through the term of the Credit Facility.

On August 31, 2021, the Company extended the Credit Facility Agreement with the Foundation by one year from November 4, 2021 to November 4, 2022. In conjunction with the extension of the Facility, the Company drew down $5,000,000 of funds from the Facility at 12% interest per annum due November 4, 2022.

Additionally, on August 31, 2021, the Company issued to the Foundation warrants, as an extension fee, to purchase 50,000 shares of the Company’s common stock exercisable for five years from the date of issuance at the exercise price of $5.89 per share. The fair value of the warrants is $137,500 and is being amortized over the 14-month line of credit period. The fair value of the warrants are treated as deferred financing costs in the accompanying consolidated balance sheets at October 31, 2021 to be amortized over the term of the Credit Facility. Total unamortized costs at October 31, 2021 were $117,857. See Note 7 for additional information related to these warrants.

At October 31, 2021 and April 30, 2021, there were $5,000,000 and no outstanding borrowings, respectively, under the Credit Facility.

The Credit Facility Agreement contains customary representations and warranties and events of default. Pursuant to the Loan Agreement and the Revolving Note, all future or contemporaneous indebtedness incurred by the Company, other than indebtedness expressly permitted by the Credit Facility Agreement and the Revolving Note, will be subordinated to the Facility.

On March 6, 2019, the Company amended and restated the Credit Facility Agreement (the “Amended and Restated Facility Agreement”) and the Revolving Note. The Amended and Restated Facility Agreement provides among other things that the Company’s obligations thereunder are secured by a first priority lien in certain deposit accounts of the Company, all current and future accounts receivable of Aspen University and USU, certain of the deposit accounts of Aspen University and USU and all of the outstanding capital stock of Aspen University and USU.Pursuant to the Credit Facility Agreement, on November 5, 2018 the Company issued to the Foundation warrants to purchase 92,049 shares of the Company’s common stock exercisable for five years from the date of issuance at the exercise price of $5.85 per share which were deemed to have a relative fair value of $255,071 (the "2018 Cooperman Warrants"). These warrants were exercised on June 8, 2020. The fair value of the warrants along with the upfront Facility fee were treated as debt issue cost assets to be amortized over the term of the loan, as the facility has not been drawn on. As a result of the aforementioned note extension, the remainder of the unamortized costs of $9,722 were written off during the quarter ended October 31, 2021. Total unamortized costs at October 31, 2021 and April 30, 2021 were $0 and $18,056, respectively

XML

Stockholders' Equity

6 Months Ended

Oct. 31, 2021

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders’ Equity

AGI maintains two stock-based incentive plans: the 2012 Equity Incentive Plan (the “2012 Plan”) and 2018 Equity Incentive Plan (the “2018 Plan”) that provides for the grant of shares in the form of incentive stock options, non-qualified stock options, restricted shares, stock appreciation rights and RSUs to employees, consultants, officers and directors.

On December 30, 2020, the Company held its Annual Meeting of Shareholders at which the shareholders voted to amend the 2018 Plan to increase the number of shares of common stock available for issuance under the 2018 Plan from 1,100,000 to 1,600,000 shares.

As of October 31, 2021 and April 30, 2021 there were 171,459 and 549,739 shares remaining available for future issuance under the 2012 and the 2018 Plans, respectively.

Restricted Stock

As of October 31, 2021, there were 8,224 unvested shares of restricted common stock outstanding. During the six months ended October 31, 2021, there were no new restricted stock grants, forfeitures, vested stock or expirations. Total unrecognized compensation expense related to the unvested shares as of October 31, 2021 was $7,018, and is expected to be recognized over a weighted-average period of approximately 0.17 years.

Restricted Stock Units

A summary of the Company’s RSU activity during the six months ended October 31, 2021 is presented below:

Restricted Stock Units	Number of Shares	Weighted Average Grant Price
Unvested balance outstanding, April 30, 2021	549,972	$	6.58
Granted	412,792	6.16
Forfeits	(28,841)	9.80
Vested	(34,820)	6.15
Expired	—	—
Unvested balance outstanding, October 31, 2021	899,103	$	5.38

Of the 412,792 RSUs granted during the six months ended October 31, 2021, 410,000 RSUs correspond to executive compensation grants summarized below.

On August 16 2021, the Compensation Committee approved a 125,000 RSU grant to the Company’s newly hired Chief Financial Officer as part of the employment agreement. The grant has a grant date fair value of $725,000 based on a closing stock price of $5.80 per share. On August 12, 2021, the Compensation Committee approved individual grants of 80,000 RSUs

to the Company’s Chief Operating Officer and Chief Academic Officer. The grants have a total grant date fair value of $1.0 million based on a closing stock price of $6.48 per share.

The three executive grants discussed above are under the Company’s 2018 Equity Incentive Plan and are set to vest annually over a period of three years and are subject to continued employment as an officer of the Company on each applicable vesting date. The amortization expense related to these grants for the three months ended October 31, 2021 was $146,817 and is included in "general and administrative expense" in the accompanying consolidated statement of operations.

On July 21, 2021, as part of a new employment agreement, the Compensation Committee approved a 125,000 RSU grant to the Company's Chief Executive Officer under the Company's 2018 Equity Incentive Plan. The grant has a grant date fair value of $873,750 based on a closing stock price of $6.99 per share. As stipulated in the grant, vesting is subject to continued employment with the Company and will occur in full on the date the Company files with the SEC a quarterly or annual report on Forms 10-Q or 10-K, as applicable, which reflects the Company's reported net income on a GAAP basis. The Company expects this condition to be met in the fourth quarter of Fiscal 2022 and is amortizing the expense over one year through July 2022 (the filing date of the Form 10-K for Fiscal Year 2022). The Company will continue to assess the performance condition at each reporting period. If the RSUs do not vest within three years from the July 21, 2021 effective date, they will be forfeited. The amortization expense related to this grant for the three and six months ended October 31, 2021 was $72,813 and $218,438, respectively, which is included in general and administrative expense in the consolidated statements of operations.

The remaining 2,792 RSU grants during the six months ended October 31, 2021 were granted to employees and have a grant date fair value that ranges from $4.92 to $6.50 per share, or a total of $16,456, vesting annually over three years and subject to continued employment on each applicable vesting date.

Of the 899,103 unvested RSUs outstanding at October 31, 2021, there are 195,000 RSUs remaining from the February 4, 2020 executive grant. These RSUs vest four years from the grant date, if each applicable executive is still employed by the Company on the vesting date and subject to accelerated vesting for all RSUs if the closing price of the Company’s common stock is at least $12 for 20 consecutive trading days. On the grant date, the closing price of the Company's common stock on The Nasdaq Global Market was $9.49 per share. The amortization expense related to these transactions for the three and six months ended October 31, 2021 and 2020, was approximately $112,155 and $224,311, and $111,211 and $1.5 million, respectively, which is included in general and administrative expense in the consolidated statements of operations.

At October 31, 2021, total unrecognized compensation expense related to unvested RSUs is $4,839,604 and is expected to be recognized over a weighted-average period of approximately 1.57 years.

Warrants

The Company estimates the fair value of warrants utilizing the Black-Scholes pricing model, which is dependent upon several variables such as the expected term, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected term and expected dividend yield rate over the expected term. The Company believes this valuation methodology is appropriate for estimating the fair value of warrants issued to directors which are subject to ASC Topic 718 requirements. These amounts are estimates and thus may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants. The Company recognizes expense on a straight-line basis over the vesting period of each warrant issued.

A summary of the Company’s warrant activity during the six months ended October 31, 2021 is presented below:

Warrants	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Balance Outstanding, April 30, 2021	374,174	$	6.37	1.90	$	—
Granted	75,000	$	6.23	4.80	—
Exercised	—	$	—	—	—
Surrendered	—	$	—	—	—
Expired	—	$	—	—	—
Balance Outstanding, October 31, 2021	449,174	$	6.35	1.96	$	—
Exercisable, October 31, 2021	424,174	$	6.31	1.80	$	—

OUTSTANDING WARRANTS					EXERCISABLE WARRANTS
Exercise Price		Weighted Average Exercise Price		Outstanding No. of Warrants	Weighted Average Exercise Price		Weighted Average Remaining Life In Years	Exercisable No. of Warrants
$	4.89	$	4.89	50,000	$	4.89	2.44	50,000
$	5.85	$	5.85	50,000	$	5.85	4.84	50,000
$	6.00	$	6.00	100,000	$	6.00	2.35	100,000
$	6.87	$	6.87	224,174	$	6.87	0.73	224,174
$	6.99	$	6.99	25,000
				449,174				424,174

On August 31, 2021, the Compensation Committee approved the issuance of warrants to the Leon and Toby Cooperman Family Foundation as an extension fee in connection with the $5 million revolving line of credit. The warrants allow for the purchase of 50,000 shares of the Company’s common stock and have an exercise price of $5.85. The warrants have an exercise period of five years from the August 31, 2021 issuance date and will terminate automatically and immediately upon the expiration of the exercise period. The fair value of the warrants is $137,500 and is being amortized over the 14-month line of credit period. The Company has recognized $19,643 of amortization expense in connection with the fair value of the warrants for the three months ending October 31, 2021, which is included in "interest expense" in the accompanying consolidated statement of operations.

On July 21, 2021, the Compensation Committee approved warrants to a former member of the Board of Directors for the purchase of 25,000 shares of the Company's common stock with an exercise price of $6.99 per share. The warrants have an exercise period of five years from the July 21, 2021 issuance date and vest annually over a three year period subject to continued service on the Company's Advisory Board on each applicable vesting date. The warrants will terminate automatically and immediately upon the expiration of the exercise period. The fair value of the warrants is $84,000 and is being amortized over the three year vesting period. The Company has recognized $7,000 and $9,333 of amortization expense in connection with the fair value of the warrants for the three and six months ending October 31, 2021, respectively, which is included in “general and administrative” expense in the accompanying consolidated statement of operations.

During the three months ended July 31, 2020, there was a warrant modification and acceleration charge of $25,966 related to the exercise of 192,049 warrants by the Leon and Toby Cooperman Family Foundation, which was included in “other (expense) income, net” in the accompanying consolidated statement of operations.

On April 10, 2019, the Company issued warrants to an advisory board member for services to purchase 50,000 shares of the Company's common stock with an exercise price of $4.89 per share. The warrants have an exercise period of five years from the April 10, 2019 issuance date and vest annually over a three year period. The warrants will terminate automatically and immediately upon the expiration of the exercise period. The fair value of the warrants is $109,500 and is being amortized over

the three year vesting period. The Company has recognized $9,125 and $18,250 of amortization expense in connection with the fair value of the warrants for the three and six months ending October 31, 2021 and 2020, respectively, which is included in “general and administrative” expense in the accompanying consolidated statement of operations.

Stock Option Grants to Employees and Directors

The Company estimates the fair value of share-based compensation utilizing the Black-Scholes option pricing model, which is dependent upon several variables such as the expected option term, expected volatility of the Company’s stock price over the expected term, expected risk-free interest rate over the expected option term and expected dividend yield rate over the expected option term. The Company believes this valuation methodology is appropriate for estimating the fair value of stock options granted to employees and directors which are subject to ASC Topic 718 requirements. These amounts are estimates and thus may not be reflective of actual future results, nor amounts ultimately realized by recipients of these grants. The Company recognizes compensation on a straight-line basis over the requisite service period for each award.

The Company utilizes the simplified method to estimate the expected life for stock options granted to employees. The simplified method was used as the Company does not have sufficient historical data regarding stock option exercises. The expected volatility is based on historical volatility. The risk-free interest rate is based on the U.S. Treasury yields with terms equivalent to the expected life of the related option at the time of the grant. Dividend yield is based on historical trends. While the Company believes these estimates are reasonable, the compensation expense recorded would increase if the expected life was increased, a higher expected volatility was used, or if the expected dividend yield increased.

A summary of the Company’s stock option activity for employees and directors during the six months ended October 31, 2021, is presented below:

Options	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Balance Outstanding, April 30, 2021	1,214,473	$	6.24	1.88	$	204,719
Granted	—	—		—	—
Exercised	(216,752)	5.77		—	—
Forfeited	(4,419)	4.61		—	—
Expired	(1,252)	2.76		—	—
Balance Outstanding, October 31, 2021	992,050	$	6.61	1.56	$	172,313
Exercisable, October 31, 2021	928,457	$	6.72	1.51	$	161,584

Of the 216,752 options exercised for 46,908 common shares during the six months ended October 31, 2021, 200,000 were cashless options exercised by the Company’s Chief Operating Officer in September 2021. As part of this cashless transactions, 30,156 net shares were issued and 169,844 were retained by the Company.

During the three and six months ended October 31, 2021 and 2020, the Company received proceeds from the exercise of stock options for cash of $33,486 and $56,034 and $945,332 and $2,215,315, respectively.

OUTSTANDING OPTIONS				EXERCISABLE OPTIONS
Exercise Price	Weighted Average Exercise Price		Outstanding Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Life In Years	Exercisable Number of Options
$3.24 to $4.38	$	3.82	179,264	$	3.81	0.78	166,597
$4.50 to $5.20	$	4.94	153,944	$	5.00	1.99	111,019
$5.95 to $6.28	$	5.95	28,000	$	5.95	0.81	28,000
$7.17 to $7.55	$	7.45	473,093	$	7.46	1.82	465,092
$8.57 to $9.07	$	8.98	157,749	$	8.98	1.18	157,749
			992,050				928,457

As of October 31, 2021, there was approximately $28,670 of unrecognized compensation costs related to unvested stock options. That cost is expected to be recognized over a weighted-average period of approximately 0.92 year.

Stock-based compensation related stock options, RSUs and restricted stock

For the three and six months ended October 31, 2021, the Company recorded stock-based compensation expense of $722,158 and $1,264,870, respectively, which consisted of: $23,504 and $108,912, $688,129 and $1,134,906 and $10,525 and $21,052, respectively, in connection with stock options, RSUs and restricted stock, which is included in “general and administrative” expense in the unaudited consolidated statements of operations.

For the three and six months ended October 31, 2020, the Company recorded stock-based compensation expense of $1,831,548 and $2,318,658, respectively, which consisted of: $142,397 and $311,131, $1,678,622 and $1,986,474 and $10,529 and $21,053, respectively, in connection with stock options, RSUs and restricted stock, which is included in “general and administrative” expense in the unaudited consolidated statements of operations.

Treasury Stock

As of both October 31, 2021 and April 30, 2021, 155,486 shares of common stock were held in treasury representing shares of common stock surrendered upon the exercise of stock options in payment of the exercise prices and the taxes and similar amounts due arising from the option exercises. The value of these shares is approximately $1.8 million and represents the fair market value of shares surrendered as of the date of each applicable exercise date.

XML

Revenue

6 Months Ended

Oct. 31, 2021

Revenue from Contract with Customer [Abstract]

Revenue

RevenueRevenue consists primarily of tuition and fees derived from courses taught by the Company online as well as from related educational resources that the Company provides to its students, such as access to our online materials and learning management system. The Company’s educational programs have starting and ending dates that differ from its fiscal quarters. Therefore, at the end of each fiscal quarter, a portion of revenue from these programs is not yet earned and is therefore deferred. The Company also charges students fees for library and technology costs, which are recognized over the related service period and are not considered separate performance obligations. Other services, books, and exam fees are recognized as services are provided or when goods are received by the student. The Company’s contract liabilities are reported as deferred revenue and due to students. Deferred revenue represents the amount of tuition, fees, and other student payments received in excess of the portion recognized as revenue and it is included in current liabilities in the accompanying consolidated balance sheets.

The following table represents our revenue disaggregated by the nature and timing of services:

	Three Months Ended October 31,				Six Months Ended October 31,
	2021		2020		2021		2020
Tuition - recognized over period of instruction	$	16,632,114	$	14,974,682	$	33,753,794	$	28,341,990
Course fees - recognized over period of instruction	1,982,771		1,786,364		3,986,111		3,386,057
Book fees - recognized at a point in time	15,018		46,037		42,777		85,175
Exam fees - recognized at a point in time	194,371		78,900		390,413		149,555
Service fees - recognized at a point in time	115,937		85,062		198,111		173,830
	$	18,940,211	$	16,971,045	$	38,371,206	$	32,136,607

Contract Balances and Performance Obligations

The Company recognizes deferred revenue as a student participates in a course which continues past the consolidated balance sheet date.

The deferred revenue balance as of April 30, 2021 was $6,825,014. During the six months ended October 31, 2021, the Company recognized $5,407,735 of revenue that was included in the deferred revenue balance as of April 30, 2021.

When the Company begins providing the performance obligation by beginning instruction in a course, a contract receivable is created, resulting in accounts receivable. The Company accounts for receivables in accordance with ASC 310, Receivables. The Company uses the portfolio approach.

Cash Receipts

Our students finance costs through a variety of funding sources, including, among others, monthly payment plans, installment plans, federal loan and grant programs (Title IV), employer reimbursement, and various veterans and military funding and grants, and cash payments. Most students elect to use our monthly payment plan. This plan allows them to make continuous monthly payments during the length of their program and through the length of their payment plan. Title IV and military funding typically arrives during the period of instruction. Students who receive reimbursement from employers typically do so after completion of a course. Students who choose to pay cash for a class typically do so before beginning the class.

Significant Judgments

We analyze revenue recognition on a portfolio approach under ASC 606-10-10-4. Significant judgment is utilized in determining the appropriate portfolios to assess for meeting the criteria to recognize revenue under ASC Topic 606. We have determined that all of our students can be grouped into one portfolio. Students behave similarly, regardless of their payment method. Enrollment agreements and refund policies are similar for all of our students. We do not expect that revenue earned for the portfolio is significantly different as compared to revenue that would be earned if we were to assess each student contract separately.

The Company maintains institutional tuition refund policies, which provides for all or a portion of tuition to be refunded if a student withdraws during stated refund periods. Certain states in which students reside impose separate, mandatory refund policies, which override the Company’s policy to the extent in conflict. If a student withdraws at a time when a portion or none of the tuition is refundable, then in accordance with its revenue recognition policy, the Company recognizes as revenue the tuition that was not refunded. Since the Company recognizes revenue pro-rata over the term of the course and because, under its institutional refund policy, the amount subject to refund is never greater than the amount of the revenue that has been deferred, under the Company’s accounting policies revenue is not recognized with respect to amounts that could potentially be refunded.

The Company had revenue from students outside the United States totaling approximately 1% of consolidated revenue for each of the three and six months ended October 31, 2021 and 2020

XML

Leases

6 Months Ended

Oct. 31, 2021

Leases [Abstract]

Leases

Leases

We determine if a contract contains a lease at inception. We have entered into operating leases totaling approximately 174,528 square feet of office and classroom space in Phoenix, San Diego, New York City, Denver, Austin, Tampa, Nashville and New Brunswick Province in Canada. These leases expire at various dates through April 2031, the majority contain annual base rent escalation clauses. Most of these leases include options to terminate for a fee or extend for additional five-year periods. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company does not have any financing leases.

As of October 31, 2021, our longer term operating leases are located in Tampa, Phoenix, Austin, and Nashville and are set to expire in seven to ten years. These leases make up 95% of the total future minimum lease payments.

Operating lease assets are right of use assets ("ROU assets"), which represent the right to use an underlying asset for the lease term. Operating lease liabilities represent the obligation to make lease payments arising from the lease. Operating leases are included in "Operating lease right of use assets, net", "Operating lease obligations, current portion" and "Operating lease obligations, less current portion" in the consolidated balance sheet at October 31, 2021 and April 30, 2021. These assets and lease liabilities are recognized based on the present value of remaining lease payments over the lease term. When the lease does not provide an implicit interest rate, the Company uses an incremental borrowing rate of 12% to determine the present value of the lease payments.

Lease incentives are deducted from the right of use assets. Incentives such as tenant improvement allowances are amortized as leasehold-improvements, separately, over the life of the lease term. For the three and six months ended October 31, 2021 and 2020, the amortization expense for these tenant improvement allowances was $152,499 and $0 and $302,887 and $0, respectively.

Lease expense for operating leases is recognized on a straight-line basis over the lease term. Lease expense for the three and six months ended October 31, 2021 and 2020 was $916,435 and $664,415 and $1,853,172 and $1,061,653, respectively, which is included in general and administrative expenses in the consolidated statements of operations.

ROU assets are summarized below:

	October 31, 2021		April 30, 2021
ROU assets - Operating facility leases	$	15,958,721	$	14,308,296
Less: accumulated reduction	(2,448,065)		(1,593,433)
Total ROU assets	$	13,510,656	$	12,714,863

Operating lease obligations, related to the ROU assets are summarized below:

	October 31, 2021		April 30, 2021
Total lease liabilities	$	22,436,658	$	19,946,229
Reduction of lease liabilities	(2,558,744)		(1,617,600)
Total operating lease obligations	$	19,877,914	$	18,328,629

The following is a schedule by fiscal years of future minimum lease payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of one year as of October 31, 2021 (a) (by fiscal year) .

Maturity of Lease Obligations	Lease Payments
2022 (remaining)	$	2,179,605
2023	4,142,637
2024	4,018,977
2025	3,802,959
2026	3,908,722
Thereafter	11,963,225
Total future minimum lease payments	30,016,125
Less: imputed interest	(10,138,211)
Present value of operating lease liabilities	$	19,877,914

_____________________

(a) Lease payments exclude $3.7 million of legally binding minimum lease payments for the new BSN Pre-Licensure campus location in a Tier 1 metropolitan area lease signed but not yet commenced.

Balance Sheet Classification	October 31, 2021		April 30, 2021
Operating lease obligations, current portion	$	2,145,431	$	2,029,821
Operating lease obligations, less current portion	17,732,483		16,298,808
Total operating lease liabilities	$	19,877,914	$	18,328,629

Other Information	October 31, 2021
Weighted average remaining lease term (in years)	7.29
Weighted average discount rate	12	%

XML

Income Taxes	6 Months Ended
	Oct. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesThe Company determined that it has a permanent establishment in Canada, as defined by article V(2)(c) of the Convention between Canada and the United States of America with Respect to Taxes on Income and on Capital (the “Treaty”), which would be subject to Canadian taxation as levied under the Income Tax Act. The Company has filed Canadian T2 Corporation Income Tax Returns and related information returns under the Voluntary Disclosure Program with the Canada Revenue Agency ("CRA") to cover the 2013 through 2021 tax years during which a permanent establishment may have been in place. As of October 31, 2021, the CRA has not yet responded to the voluntary disclosure. The Company will also file an annual Canadian T2 Corporation Income Tax return to report the ongoing activity of the permanent establishment for the 2022 and future taxation years.As of October 31, 2021, the Company recorded a reserve of approximately $150,000 for the estimate of a multi-year foreign income tax liability.

XML

Commitments and Contingencies

6 Months Ended

Oct. 31, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Employment Agreements

From time to time, the Company enters into employment agreements with certain of its employees. These agreements typically include bonuses, some of which may or may not be performance-based in nature.

Legal Matters

From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of October 31, 2021, except as discussed below, there were no other pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of our consolidated operations and there are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

On February 11, 2013, HEMG, and its Chairman, Mr. Patrick Spada, sued the Company, certain senior management members and our directors in state court in New York seeking damages arising principally from (i) allegedly false and misleading statements in the filings with the SEC and the DOE where the Company disclosed that HEMG and Mr. Spada borrowed $2.2 million without board authority, (ii) the alleged breach of an April 2012 agreement whereby the Company had agreed, subject to numerous conditions and time limitations, to purchase certain shares of the Company from HEMG, and (iii) alleged diminution to the value of HEMG’s shares of the Company due to Mr. Spada’s disagreement with certain business transactions the Company engaged in, all with Board approval.

On December 10, 2013, the Company filed a series of counterclaims against HEMG and Mr. Spada in the same state court of New York. By order dated August 4, 2014, the New York court denied HEMG and Spada’s motion to dismiss the fraud counterclaim the Company asserted against them.

In November 2014, the Company and Aspen University sued HEMG seeking to recover sums due under two 2008 Agreements where Aspen University sold course materials to HEMG in exchange for long-term future payments. On September 29, 2015, the Company and Aspen University obtained a default judgment in the amount of $772,793. This default judgment precipitated the bankruptcy petition discussed in the next paragraph.

On July 21, 2021, the bankruptcy trustee paid the Company $498,120 based on assets available in the trust, which is included in "other income (expense), net" in the accompanying consolidated statements of operations. As a result, the Company wrote off the net receivable of $45,329, described in Note 5, at July 31, 2021. No further assets are available for distribution. At some point, the New York state court litigation may resume.

Regulatory Matters

The Company’s subsidiaries, Aspen University and United States University, are subject to extensive regulation by Federal and State governmental agencies and accrediting bodies. In particular, the Higher Education Act (the “HEA”) and the regulations promulgated thereunder by the DOE subject the subsidiaries to significant regulatory scrutiny on the basis of numerous standards that schools must satisfy to participate in the various types of federal student financial assistance programs authorized under Title IV of the HEA.

On August 22, 2017, the DOE informed Aspen University of its determination that the institution has qualified to participate under the HEA and the Federal student financial assistance programs (Title IV, HEA programs) and set a subsequent program participation agreement reapplication date of March 31, 2021. On April 16, 2021, the DOE granted provisional certification for a two-year timeframe, and set a subsequent program participation reapplication date of September 30, 2023.

USU currently has provisional certification to participate in the Title IV Programs due to its acquisition by the Company. The provisional certification allows the school to continue to receive Title IV funding as it did prior to the change of ownership. The provisional certification expired on December 31, 2020. While the institution submitted its recertification application timely in October 2020, the DOE has not issued its final certification. The institution is able to continue operating under its current participation agreement until the DOE issues its recertification.

The HEA requires accrediting agencies to review many aspects of an institution's operations in order to ensure that the education offered is of sufficiently high quality to achieve satisfactory outcomes and that the institution is complying with accrediting standards. Failure to demonstrate compliance with accrediting standards may result in the imposition of probation, the requirements to provide periodic reports, the loss of accreditation or other penalties if deficiencies are not remediated.

Because our subsidiaries operate in a highly regulated industry, each may be subject from time to time to audits, investigations, claims of noncompliance or lawsuits by governmental agencies or third parties, which allege statutory violations, regulatory infractions or common law causes of action.

Title IV Funding

Aspen University and United States University derive a portion of their revenue from financial aid received by its students under programs authorized by Title IV of the HEA, which are administered by the US Department of Education. When students seek funding from the federal government, they receive loans and grants to fund their education under the following Title IV Programs: (1) the Federal Direct Loan program, or Direct Loan; (2) the Federal Pell Grant program, or Pell; (3) Federal Work Study and (4) Federal Supplemental Opportunity Grants. For the fiscal year ended April 30, 2021, 44.72% of Aspen University’s and 33.81% for United States University's cash-basis revenue for eligible tuition and fees were derived from Title IV Programs.

Return of Title IV Funds

An institution participating in Title IV Programs must correctly calculate the amount of unearned Title IV Program funds that have been disbursed to students who withdraw from their educational programs before completion and must return those unearned funds in a timely manner, no later than 45 days of the date the school determines that the student has withdrawn. Under the DOE regulations, failure to make timely returns of Title IV Program funds for 5% or more of students sampled on the institution's annual compliance audit in either of its two most recently completed fiscal years can result in the institution having to post a letter of credit in an amount equal to 25% of its required Title IV returns during its most recently completed fiscal year. If unearned funds are not properly calculated and returned in a timely manner, an institution is also subject to monetary liabilities or an action to impose a fine or to limit, suspend or terminate its participation in Title IV Programs.

On September 28, 2020, the DOE notified USU that the funds held for a letter of credit in the amount of $255,708, based on the audited same day balance sheet requirements that apply in a change of control, which was funded by the University’s sole shareholder, AGI, were released. In August 2020, the DOE informed USU that it is required to post a new letter of credit in the amount of $379,345, based on the current level of Title IV funding. This irrevocable letter of credit was to expire on August 25, 2021. Pursuant to USU’s provisional Program Participation Agreement ("PPA"), the DOE indicated that USU must agree to participate in Title IV under the HCM1 funding process; however, the DOE does retain discretion on whether or not to implement that term of the agreement. Although DOE has not, to date, notified USU that it has been placed in the HCM1 funding process, nor does the DOE’s public disclosure website identify USU as being on HCM1, it is possible that prior to the end of the PPA term, the DOE may notify USU that it must begin funding under the HCM1 procedure. If this occurs, the Company believes this will not have a material impact on the consolidated financial statements. In December 2020, the DOE reduced USU's existing letter of credit by $369,473, which was required to be posted based on the level of Title IV funding. In connection with USU's most recent Compliance Audit, USU currently maintains a letter of credit of $9,872 at October 31, 2021.

Approval to Confer Degrees

Aspen University is a Delaware corporation and is approved to operate in the State of Delaware. Aspen University is authorized by the Colorado Commission on Education in the State of Colorado and the Arizona State Board for Private Post-Secondary Education in the State of Arizona to operate as a degree granting institution for all degrees. Aspen University is authorized to operate as a degree granting institution for bachelor degrees by the Texas Higher Education Coordinating Board in the State of Texas. Aspen University has been granted Optional Expedited Authorization as a postsecondary educational institution in Tennessee for its Bachelor of Science in Nursing (Pre-Licensure) degree program. Aspen University has received a Provisional License for its Bachelor of Science in Nursing (Pre-Licensure) degree program to operate in the state of Florida by the Commission for Independent Education of the Florida Department of Education and is in the process for full licensure.

USU is also a Delaware corporation and received initial approval from the Delaware DOE to confer degrees through June 2023. United States University is authorized by the California Bureau of Private Postsecondary Education and the Arizona State Board for Private Post-Secondary Education to operate as degree granting institutions for all degrees.

XML

Significant Accounting Policies (Policies)

6 Months Ended

Oct. 31, 2021

Accounting Policies [Abstract]

Basis of Presentation and Consolidation

Basis of Presentation and Consolidation

The Company prepares its consolidated financial statements in accordance with U.S. generally accepted accounting principles ("GAAP").

The consolidated financial statements include the accounts of AGI and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Accounting Estimates

Accounting Estimates

Management of the Company is required to make certain estimates, judgments and assumptions during the preparation of its consolidated financial statements in accordance with GAAP. These estimates, judgments and assumptions impact the reported amounts of assets, liabilities, revenue and expenses and the related disclosure of contingent assets and liabilities. Actual results could differ from those estimates.

Significant estimates in the accompanying consolidated financial statements include the allowance for doubtful accounts and other receivables, the valuation of lease liabilities and the carrying value of the related right-of-use ("ROU") assets, depreciable lives of property and equipment, amortization periods and valuation of courseware, intangibles and software development costs, valuation of goodwill, valuation of loss contingencies, valuation of stock-based compensation and the valuation allowance on deferred tax assets.

Cash, Cash Equivalents, and Restricted Cash

Cash, Cash Equivalents, and Restricted Cash

For the purposes of the consolidated statements of cash flows, the Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.

Restricted cash as of October 31, 2021 of $1,433,397 consists of $1,173,525 which is collateral for letters of credit for the Aspen University and USU facility operating leases, $9,872 which is collateral for a letter of credit for USU required to be posted based on the level of Title IV funding in connection with USU's most recent Compliance Audit, and a $250,000 compensating balance under a secured credit line.

Restricted cash as of April 30, 2021 of $1,193,997 consisted of $934,125 which is collateral for letters of credit for the Aspen University and USU facility operating leases, $9,872 which is collateral for a letter of credit for USU required to be posted based on the level of Title IV funding in connection with USU's most recent Compliance Audit, and a $250,000 compensating balance under a secured credit line.

Concentration of Credit Risk

Concentration of Credit RiskThe Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits of $250,000 per financial institution. The Company has not experienced any losses in such accounts from inception through October 31, 2021.

Revenue Recognition and Deferred Revenue

Revenue Recognition and Deferred Revenue

The Company follows Accounting Standards Codification 606 (ASC 606). ASC 606 is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASC also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer purchase orders, including significant judgments.

Revenue consists primarily of tuition and course fees derived from courses taught by the Company online and in-person as well as from related educational resources and services that the Company provides to its students. Under ASC 606, tuition and course fee revenue is recognized pro-rata over the applicable period of instruction and are not considered separate performance obligations.  Non-tuition related revenue and fees are recognized as services are provided or when the goods are received by the student. (See Note 8) Students may receive discounts, scholarships, or refunds, which gives rise to variable consideration. The amounts of discounts or scholarships are applied to individual student accounts when such amounts are awarded. Therefore, the tuition is reduced directly by these discounts or scholarships from the amount of the standard tuition rate charged.

Deferred revenue represents the amount of tuition, fees, and other student payments received in excess of the portion recognized as revenue and it is included in current liabilities in the accompanying consolidated balance sheets. Other revenue may be recognized as sales occur or services are performed.

Net Loss Per Share

Net Loss Per Share

Net loss per share is based on the weighted average number of shares of common stock outstanding during each period. Options to purchase 992,050 and 1,214,473 shares of common stock, 899,103 and 549,972 restricted stock units ("RSUs"), warrants to purchase 449,174 and 374,174 shares of common stock, and unvested restricted stock of 8,224 and 8,224 were outstanding at October 31, 2021 and April 30, 2021, respectively.

All shares mentioned above were not included in the computation of diluted net loss per share because the effects would have been anti-dilutive. The options, warrants, RSUs and unvested restricted stock are considered to be common stock equivalents and are only included in the calculation of diluted earnings per share of common stock when their effect is dilutive.

Segment Information

Segment Information

The Company operates in one reportable segment as a single educational delivery operation using a core infrastructure that serves the curriculum and educational delivery needs of its online and campus students regardless of geography. The Company's chief operating decision makers, its Chief Executive Officer, Chief Operating Officer and Chief Academic Officer, manage the Company's operations as a whole.

Recent Accounting Pronouncement Not Yet Adopted

Recent Accounting Pronouncement Not Yet Adopted

ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which significantly changes how entities will measure credit losses for most financial assets, including accounts receivable. ASU No. 2016-13 will replace today’s “incurred loss” approach with an “expected loss” model, under which companies will recognize allowances based on expected rather than incurred losses. On November 15, 2019, the FASB delayed the effective date of Topic 326 for certain small public companies and other private companies until fiscal years

beginning after December 15, 2022 for SEC filers that are eligible to be smaller reporting companies under the SEC’s definition, as well as private companies and not-for-profit entities. The Company is currently evaluating the new guidance and has not yet determined whether the adoption of the new standard will have a material impact on its consolidated financial statements or the method of adoption.

Reclassifications

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year presentation.

The Company has concluded that based on industry practices, the preferred presentation for cash received in advance for unearned tuition and stipends should be reclassified from "restricted cash" to "cash and cash equivalents." The cash balance of $3,958,793 for funds held for students for unbilled educational services that were received from Title IV and non-Title IV programs at April 30, 2021, which was previously included in "restricted cash" in the accompanying consolidated balance sheet, was reclassified to "cash and cash equivalents" to align with the current year presentation. There is no impact to total current assets included in accompanying consolidated balance sheet at April 30, 2021. The restricted cash balance at April 30, 2021, now includes letters of credit and a compensating balance under a secured credit line of $1,193,997.

XML

Property and Equipment (Tables)

6 Months Ended

Oct. 31, 2021

Property, Plant and Equipment [Abstract]

Schedule of Software

Software consisted of the following:

	October 31, 2021		April 30, 2021
Software	$	9,386,352	$	8,488,635
Accumulated amortization	(4,284,129)		(3,444,325)
Software, net	$	5,102,223	$	5,044,310

Courseware and accreditation consisted of the following:

	October 31, 2021		April 30, 2021
Courseware	$	557,973	$	408,222
Accreditation	59,350		59,350
	617,323		467,572
Accumulated amortization	(317,409)		(280,276)
Courseware and accreditation, net	$	299,914	$	187,296

Depreciation and Amortization Expense

Depreciation and amortization expense for property and equipment and software is summarized below:

	Three Months Ended October 31,				Six Months Ended October 31,
	2021		2020		2021		2020
Depreciation and amortization expense:
Property and equipment, excluding software	$	367,475	$	164,204	$	718,848	$	327,774
Software	$	428,143	$	346,653	$	839,804	$	661,760

XML

Courseware and Accreditation (Tables)

6 Months Ended

Oct. 31, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Courseware and Accreditation

Software consisted of the following:

	October 31, 2021		April 30, 2021
Software	$	9,386,352	$	8,488,635
Accumulated amortization	(4,284,129)		(3,444,325)
Software, net	$	5,102,223	$	5,044,310

Courseware and accreditation consisted of the following:

	October 31, 2021		April 30, 2021
Courseware	$	557,973	$	408,222
Accreditation	59,350		59,350
	617,323		467,572
Accumulated amortization	(317,409)		(280,276)
Courseware and accreditation, net	$	299,914	$	187,296

Schedule of Amortization Expense of Courseware and Accreditation

Amortization expense for courseware and accreditation is summarized below:

	Three Months Ended October 31,				Six Months Ended October 31,
	2021		2020		2021		2020
Amortization expense	$	21,185	$	10,516	$	37,133	$	22,463

XML

Stockholders' Equity (Tables)

6 Months Ended

Oct. 31, 2021

Stockholders' Equity Note [Abstract]

Schedule of Restricted Stock Unit Activity

A summary of the Company’s RSU activity during the six months ended October 31, 2021 is presented below:

Restricted Stock Units	Number of Shares	Weighted Average Grant Price
Unvested balance outstanding, April 30, 2021	549,972	$	6.58
Granted	412,792	6.16
Forfeits	(28,841)	9.80
Vested	(34,820)	6.15
Expired	—	—
Unvested balance outstanding, October 31, 2021	899,103	$	5.38

Summary of Warrant Activity

A summary of the Company’s warrant activity during the six months ended October 31, 2021 is presented below:

Warrants	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Balance Outstanding, April 30, 2021	374,174	$	6.37	1.90	$	—
Granted	75,000	$	6.23	4.80	—
Exercised	—	$	—	—	—
Surrendered	—	$	—	—	—
Expired	—	$	—	—	—
Balance Outstanding, October 31, 2021	449,174	$	6.35	1.96	$	—
Exercisable, October 31, 2021	424,174	$	6.31	1.80	$	—

Share-based Payment Arrangement, Option, Exercise Price Range

OUTSTANDING WARRANTS					EXERCISABLE WARRANTS
Exercise Price		Weighted Average Exercise Price		Outstanding No. of Warrants	Weighted Average Exercise Price		Weighted Average Remaining Life In Years	Exercisable No. of Warrants
$	4.89	$	4.89	50,000	$	4.89	2.44	50,000
$	5.85	$	5.85	50,000	$	5.85	4.84	50,000
$	6.00	$	6.00	100,000	$	6.00	2.35	100,000
$	6.87	$	6.87	224,174	$	6.87	0.73	224,174
$	6.99	$	6.99	25,000
				449,174				424,174

OUTSTANDING OPTIONS				EXERCISABLE OPTIONS
Exercise Price	Weighted Average Exercise Price		Outstanding Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Life In Years	Exercisable Number of Options
$3.24 to $4.38	$	3.82	179,264	$	3.81	0.78	166,597
$4.50 to $5.20	$	4.94	153,944	$	5.00	1.99	111,019
$5.95 to $6.28	$	5.95	28,000	$	5.95	0.81	28,000
$7.17 to $7.55	$	7.45	473,093	$	7.46	1.82	465,092
$8.57 to $9.07	$	8.98	157,749	$	8.98	1.18	157,749
			992,050				928,457

Summary of Stock Option Activity

A summary of the Company’s stock option activity for employees and directors during the six months ended October 31, 2021, is presented below:

Options	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Balance Outstanding, April 30, 2021	1,214,473	$	6.24	1.88	$	204,719
Granted	—	—		—	—
Exercised	(216,752)	5.77		—	—
Forfeited	(4,419)	4.61		—	—
Expired	(1,252)	2.76		—	—
Balance Outstanding, October 31, 2021	992,050	$	6.61	1.56	$	172,313
Exercisable, October 31, 2021	928,457	$	6.72	1.51	$	161,584

XML

Revenue (Tables)

6 Months Ended

Oct. 31, 2021

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table represents our revenue disaggregated by the nature and timing of services:

	Three Months Ended October 31,				Six Months Ended October 31,
	2021		2020		2021		2020
Tuition - recognized over period of instruction	$	16,632,114	$	14,974,682	$	33,753,794	$	28,341,990
Course fees - recognized over period of instruction	1,982,771		1,786,364		3,986,111		3,386,057
Book fees - recognized at a point in time	15,018		46,037		42,777		85,175
Exam fees - recognized at a point in time	194,371		78,900		390,413		149,555
Service fees - recognized at a point in time	115,937		85,062		198,111		173,830
	$	18,940,211	$	16,971,045	$	38,371,206	$	32,136,607

XML

Leases (Tables)

6 Months Ended

Oct. 31, 2021

Leases [Abstract]

Schedule of Right-of-Use Assets and Operating Lease Liabilities

ROU assets are summarized below:

	October 31, 2021		April 30, 2021
ROU assets - Operating facility leases	$	15,958,721	$	14,308,296
Less: accumulated reduction	(2,448,065)		(1,593,433)
Total ROU assets	$	13,510,656	$	12,714,863

Operating lease obligations, related to the ROU assets are summarized below:

	October 31, 2021		April 30, 2021
Total lease liabilities	$	22,436,658	$	19,946,229
Reduction of lease liabilities	(2,558,744)		(1,617,600)
Total operating lease obligations	$	19,877,914	$	18,328,629

Future Minimum Payments Under Operating Leases

The following is a schedule by fiscal years of future minimum lease payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of one year as of October 31, 2021 (a) (by fiscal year) .

Maturity of Lease Obligations	Lease Payments
2022 (remaining)	$	2,179,605
2023	4,142,637
2024	4,018,977
2025	3,802,959
2026	3,908,722
Thereafter	11,963,225
Total future minimum lease payments	30,016,125
Less: imputed interest	(10,138,211)
Present value of operating lease liabilities	$	19,877,914

_____________________

(a) Lease payments exclude $3.7 million of legally binding minimum lease payments for the new BSN Pre-Licensure campus location in a Tier 1 metropolitan area lease signed but not yet commenced.

Schedule of Balance Sheet Information Related to Leases

Balance Sheet Classification	October 31, 2021		April 30, 2021
Operating lease obligations, current portion	$	2,145,431	$	2,029,821
Operating lease obligations, less current portion	17,732,483		16,298,808
Total operating lease liabilities	$	19,877,914	$	18,328,629

Schedule of Other Information Related to Leases

Other Information	October 31, 2021
Weighted average remaining lease term (in years)	7.29
Weighted average discount rate	12	%

XML

Nature of Operations (Details)	5 Months Ended	6 Months Ended	24 Months Ended
	Oct. 31, 2021 student subsidiary	Oct. 31, 2021 student location subsidiary	Oct. 31, 2021 student subsidiary
Degree-Seeking Nursing Student [Line Items]
Number of subsidiaries | subsidiary	2	2	2
Percentage of nursing students seeking degree	87.00%	87.00%	87.00%
Number of degree-seeking nursing students	12,442	12,442	12,442
Number of students	14,318	14,318	14,318
Number of metro locations | location		4
Aspen Nursing
Degree-Seeking Nursing Student [Line Items]
Increase (decrease) in course registration (as a percent)	3.00%		10.00%
BSN Pre-Licensure Program
Degree-Seeking Nursing Student [Line Items]
Number of degree-seeking nursing students	2,500	2,500	2,500
Registered Nurses (RNs)
Degree-Seeking Nursing Student [Line Items]
Percentage of nursing students seeking degree	69.00%	69.00%	69.00%
Number of degree-seeking nursing students	9,942	9,942	9,942

XML

Significant Accounting Policies (Details)	6 Months Ended
	Oct. 31, 2021 USD ($) segment shares	Apr. 30, 2021 USD ($) shares	Dec. 31, 2020 USD ($)
Short-term Debt [Line Items]
Restricted cash | $	$ 1,433,397	$ 1,193,997
Cash, uninsured amount | $	$ 11,765,690	13,005,537
Outstanding (in shares) | shares	992,050
Number of reportable segments | segment	1
Collateral Pledged, Aspen University Letter of Credit
Short-term Debt [Line Items]
Restricted cash | $	$ 1,173,525	934,125
Collateral Pledged, Bank Letter of Credit
Short-term Debt [Line Items]
Restricted cash | $	9,872	9,872	$ 369,473
Secured Credit Line
Short-term Debt [Line Items]
Restricted cash | $	$ 250,000	250,000
Unbilled Educational Services
Short-term Debt [Line Items]
Restricted cash | $		$ 3,958,793
Stock Incentive Plan and Stock Option Grants to Employees and Directors
Short-term Debt [Line Items]
Outstanding (in shares) | shares	992,050	1,214,473
Restricted Stock Units (RSUs)
Short-term Debt [Line Items]
Unvested shares of restricted common stock outstanding (in shares) | shares	899,103	549,972
Warrant
Short-term Debt [Line Items]
Outstanding (in shares) | shares	449,174
Exercisable awards (in shares) | shares	424,174	374,174
Restricted Stock
Short-term Debt [Line Items]
Unvested shares of restricted common stock outstanding (in shares) | shares	8,224	8,224

XML

Property and Equipment - Schedule of Software (Details) - USD ($)	Oct. 31, 2021	Apr. 30, 2021
Property, Plant and Equipment [Line Items]
Software	$ 617,323	$ 467,572
Software
Property, Plant and Equipment [Line Items]
Software	9,386,352	8,488,635
Accumulated amortization	(4,284,129)	(3,444,325)
Total	$ 5,102,223	$ 5,044,310

XML

Property and Equipment - Depreciation and Amortization Expense (Details) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Property, Plant and Equipment [Abstract]
Property and equipment, excluding software	$ 367,475	$ 164,204	$ 718,848	$ 327,774
Software	$ 428,143	$ 346,653	$ 839,804	$ 661,760

XML

Courseware and Accreditation - Schedule of Courseware and Accreditation (Details) - USD ($)	Oct. 31, 2021	Apr. 30, 2021
Finite-Lived Intangible Assets [Line Items]
Software	$ 617,323	$ 467,572
Courseware
Finite-Lived Intangible Assets [Line Items]
Software	557,973	408,222
Accreditation
Finite-Lived Intangible Assets [Line Items]
Software	59,350	59,350
Courseware, net
Finite-Lived Intangible Assets [Line Items]
Accumulated amortization	(317,409)	(280,276)
Total	$ 299,914	$ 187,296

XML

Courseware and Accreditation -Schedule of Amortization Expense of Courseware and Accreditation (Details) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Courseware, net
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 21,185	$ 10,516	$ 37,133	$ 22,463

XML

Secured Note and Accounts Receivable (Details) - HEMG - USD ($)	Jul. 31, 2021	Jul. 21, 2021
Related Party Transaction [Line Items]
Proceeds from bankruptcy claims		$ 498,120
Writeoff of net receivable	$ 45,329

XML

Long-term Debt (Details) - USD ($)	Aug. 31, 2021	Nov. 05, 2018	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2021
Debt Instrument [Line Items]
Deferred financing costs			$ 117,857		$ 18,056
Warrant
Debt Instrument [Line Items]
Vesting period of warrant	5 years
Credit Facility Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit, maximum borrowing capacity	$ 5,000,000	$ 5,000,000
Interest rate of debt (as a percent)	12.00%	12.00%
Debt instrument, extension term	1 year
Proceeds from lines of credit	$ 5,000,000
Deferred financing costs			0	$ 9,722	18,056
Line of credit, outstanding balance			$ 5,000,000		$ 0
Credit Facility Agreement | Revolving Credit Facility | Warrant
Debt Instrument [Line Items]
Number of securities called by warrants or rights (in shares)	50,000	92,049
Vesting period of warrant	14 months
Exercise price of warrants (in dollars per share)	$ 5.89	$ 5.85
Fair value of warrants outstanding	$ 137,500	$ 255,071
Warrant term		5 years

XML

Stockholders' Equity - Narrative (Details)							3 Months Ended			6 Months Ended
	Aug. 31, 2021 USD ($) $ / shares shares	Aug. 16, 2021 USD ($) $ / shares shares	Aug. 12, 2021 USD ($) $ / shares shares	Jul. 21, 2021 USD ($) $ / shares shares	Feb. 04, 2020 $ / shares	Apr. 10, 2019 USD ($) $ / shares shares	Oct. 31, 2021 USD ($) plan shares	Oct. 31, 2020 USD ($) shares	Jul. 31, 2020 USD ($) shares	Oct. 31, 2021 USD ($) plan $ / shares shares	Oct. 31, 2020 USD ($) shares	Apr. 30, 2021 USD ($) shares	Dec. 30, 2020 shares	Dec. 29, 2020 shares	Nov. 05, 2018 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock-based incentive plans | plan							2			2
Common stock, shares authorized (in shares) | shares							40,000,000			40,000,000		40,000,000
Share price (in dollars per share) | $ / shares					$ 9.49
Amortization of deferred financing costs | $										$ 19,643	$ 0
Modification charge for warrants exercised | $											25,966
Common stock issued for stock options exercised for cash | $							$ 33,486	$ 945,332		56,034	2,215,315
Unrecognized compensation costs | $							28,670			28,670
Stock based compensation expense | $							$ 722,158	$ 1,831,548		$ 1,264,870	$ 2,318,658
Treasury stock (in shares) | shares							155,486			155,486		155,486
Treasury stock, value | $							$ 1,817,414			$ 1,817,414		$ 1,817,414
Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock issued for stock options exercised for cash (in shares) | shares							11,655	502,412		16,752	917,587
Common stock issued for cashless stock options exercised (in shares) | shares							30,156	22,339		30,156	22,339
Common stock issued for cashless stock options exercised, retained by company (in shares) | shares										169,844
Common stock issued for stock options exercised for cash | $							$ 12	$ 502		$ 17	$ 918
Revolving Credit Facility | Credit Facility Agreement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Line of credit, maximum borrowing capacity | $	$ 5,000,000														$ 5,000,000
Cooperman Warrants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of securities called by warrants or rights (in shares) | shares									192,049
Modification charge for warrants exercised | $									$ 25,966
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested shares of restricted common stock outstanding (in shares) | shares							8,224			8,224		8,224
Total unrecognized compensation expense | $							$ 7,018			$ 7,018
Weighted average recognition period										2 months 1 day
Stock based compensation expense | $							$ 10,525	10,529		$ 21,052	21,053
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested shares of restricted common stock outstanding (in shares) | shares							899,103			899,103		549,972
Total unrecognized compensation expense | $							$ 4,839,604			$ 4,839,604
Weighted average recognition period										1 year 6 months 25 days
Restricted shares granted (in shares) | shares										412,792
Fair value of RSUs | $			$ 1,000,000
Share price (in dollars per share) | $ / shares			$ 6.48
Amortization expense | $							112,155	111,211		$ 224,311	1,500,000
Stock based compensation expense | $							$ 688,129	1,678,622		$ 1,134,906	1,986,474
Restricted Stock Units (RSUs) | Share-based Payment Arrangement, Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares granted (in shares) | shares										410,000
Restricted Stock Units (RSUs) | Share-based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested shares of restricted common stock outstanding (in shares) | shares							195,000			195,000
Weighted average recognition period					4 years
Minimum closing price of common stock (in dollars per share) | $ / shares					$ 12
Consecutive trading days					20 days
Restricted Stock Units (RSUs) | Chief Financial Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares granted (in shares) | shares		125,000
Fair value of RSUs | $		$ 725,000
Share price (in dollars per share) | $ / shares		$ 5.80
Restricted Stock Units (RSUs) | Chief Operating Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares granted (in shares) | shares			80,000
Restricted Stock Units (RSUs) | Chief Academic Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares granted (in shares) | shares			80,000
Restricted Stock Units (RSUs) | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares granted (in shares) | shares				125,000
Fair value of RSUs | $				$ 873,750
Share price (in dollars per share) | $ / shares				$ 6.99
Amortization expense | $							$ 72,813			$ 218,438
Amortization period of expense				1 year
Expiration period of award				3 years
Restricted Stock Units (RSUs) | Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted shares granted (in shares) | shares										2,792
Fair value of RSUs | $							16,456			$ 16,456
Vesting period of award (in years)										3 years
Restricted Stock Units (RSUs) | Employees | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant price of award (in dollars per share) | $ / shares										$ 4.92
Restricted Stock Units (RSUs) | Employees | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant price of award (in dollars per share) | $ / shares										$ 6.50
Warrant
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period of warrant	5 years
Warrant | Revolving Credit Facility | Credit Facility Agreement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of securities called by warrants or rights (in shares) | shares	50,000														92,049
Exercise price of warrants (in dollars per share) | $ / shares	$ 5.89														$ 5.85
Fair value of warrants outstanding | $	$ 137,500														$ 255,071
Vesting period of warrant	14 months
Warrant | Leon and Toby Cooperman Family Foundation
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of securities called by warrants or rights (in shares) | shares	50,000
Exercise price of warrants (in dollars per share) | $ / shares	$ 5.85
Exercise period of warrant	5 years
Warrant | Former Board of Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Amortization expense | $							7,000			$ 9,333
Number of securities called by warrants or rights (in shares) | shares				25,000
Exercise price of warrants (in dollars per share) | $ / shares				$ 6.99
Exercise period of warrant				5 years
Fair value of warrants outstanding | $				$ 84,000
Vesting period of warrant				3 years
Warrant | Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Amortization expense | $							9,125			$ 18,250
Number of securities called by warrants or rights (in shares) | shares						50,000
Exercise price of warrants (in dollars per share) | $ / shares						$ 4.89
Exercise period of warrant						5 years
Fair value of warrants outstanding | $						$ 109,500
Vesting period of warrant						3 years
Stock Incentive Plan and Stock Option Grants to Employees and Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock issued for stock options exercised for cash (in shares) | shares										216,752
Common stock issued for stock options exercised (in shares) | shares										46,908
Stock Incentive Plan and Stock Option Grants to Employees and Directors | Chief Operating Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock issued for stock options exercised for cash (in shares) | shares										200,000
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average recognition period										11 months 1 day
Stock based compensation expense | $							$ 23,504	$ 142,397		$ 108,912	$ 311,131
2018 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares) | shares													1,600,000	1,100,000
Common stock, shares remaining for future issuance (in shares) | shares							549,739			549,739		549,739
2018 Equity Incentive Plan | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average recognition period										3 years
Amortization expense | $							$ 146,817
Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares remaining for future issuance (in shares) | shares							171,459			171,459		171,459

XML

Stockholders' Equity - Schedule of Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs)	6 Months Ended
	Oct. 31, 2021 $ / shares shares
Number of Shares
Unvested Balance Outstanding at April 30, 2021 (in shares) | shares	549,972
Granted (in shares) | shares	412,792
Forfeited (in shares) | shares	(28,841)
Vested (in shares) | shares	(34,820)
Expired (in shares) | shares	0
Unvested Balance Outstanding, October 31, 2021 (in shares) | shares	899,103
Weighted Average Grant Price
Unvested Balance Outstanding at April 30, 2021 (in dollars per share) | $ / shares	$ 6.58
Granted (in dollars per share) | $ / shares	6.16
Forfeits (in dollars per share) | $ / shares	9.80
Vested (in dollars per share) | $ / shares	6.15
Expired (in dollars per share) | $ / shares	0
Unvested Balance Outstanding at October 31, 2021 (in dollars per share) | $ / shares	$ 5.38

XML

Stockholders' Equity - Summary of Warrant Activity (Details) - Warrant - USD ($)			6 Months Ended
	Oct. 31, 2021	Apr. 30, 2021	Oct. 31, 2021
Number of Shares
Balance Outstanding, April 30, 2021 (in shares)			374,174
Granted (in shares)			75,000
Warrants exercised (in shares)			0
Surrendered (in shares)			0
Expired (in shares)			0
Balance Outstanding, October 31, 2021 (in shares)	449,174	374,174	449,174
Exercisable, October 31, 2021 (in shares)	424,174	374,174	424,174
Weighted Average Exercise Price
Balance Outstanding, April 30, 2021 (in dollars per share)			$ 6.37
Granted (in dollars per share)			6.23
Exercised (in dollars per share)			0
Surrendered (in dollars per share)			0
Expired (in dollars per share)			0
Balance Outstanding, October 31, 2021 (in dollars per share)	$ 6.35	$ 6.37	6.35
Exercisable, October 31, 2021 (in dollars per share)	$ 6.31		$ 6.31
Weighted Average Remaining Contractual Term
Weighted Average Remaining Contractual Term, Outstanding	1 year 11 months 15 days	1 year 10 months 24 days
Weighted Average Remaining Contractual Term, Granted			4 years 9 months 18 days
Weighted Average Remaining Contractual Term, Exercisable	1 year 9 months 18 days
Aggregate Intrinsic Value
Average Intrinsic Value	$ 0	$ 0	$ 0
Aggregate Intrinsic Value, Exercisable	$ 0		$ 0

XML

Stockholders' Equity - Share-based Payment Arrangement, Option, Exercise Price Range (Details)	6 Months Ended
	Oct. 31, 2021 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding (in shares) | shares	992,050
Exercisable (in shares) | shares	928,457
Warrant
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding (in shares) | shares	449,174
Exercisable (in shares) | shares	424,174
Warrant | $4.89
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum exercise price (in dollars per share)	$ 4.89
Maximum exercise price (in dollars per share)	4.89
Weighted average exercise price (in dollars per share)	$ 4.89
Outstanding (in shares) | shares	50,000
Weighted average exercise price (in dollars per share)	$ 4.89
Weighted average remaining life in years	2 years 5 months 8 days
Exercisable (in shares) | shares	50,000
Warrant | $5.85
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum exercise price (in dollars per share)	$ 5.85
Maximum exercise price (in dollars per share)	5.85
Weighted average exercise price (in dollars per share)	$ 5.85
Outstanding (in shares) | shares	50,000
Weighted average exercise price (in dollars per share)	$ 5.85
Weighted average remaining life in years	4 years 10 months 2 days
Exercisable (in shares) | shares	50,000
Warrant | $6.00
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum exercise price (in dollars per share)	$ 6.00
Maximum exercise price (in dollars per share)	6.00
Weighted average exercise price (in dollars per share)	$ 6.00
Outstanding (in shares) | shares	100,000
Weighted average exercise price (in dollars per share)	$ 6.00
Weighted average remaining life in years	2 years 4 months 6 days
Exercisable (in shares) | shares	100,000
Warrant | $6.87
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum exercise price (in dollars per share)	$ 6.87
Maximum exercise price (in dollars per share)	6.87
Weighted average exercise price (in dollars per share)	$ 6.87
Outstanding (in shares) | shares	224,174
Weighted average exercise price (in dollars per share)	$ 6.87
Weighted average remaining life in years	8 months 23 days
Exercisable (in shares) | shares	224,174
Warrant | $6.99
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum exercise price (in dollars per share)	$ 6.99
Maximum exercise price (in dollars per share)	6.99
Weighted average exercise price (in dollars per share)	$ 6.99
Outstanding (in shares) | shares	25,000

XML

Stockholders' Equity - Summary of Stock Option Activity (Details)			6 Months Ended
	Oct. 31, 2021 USD ($) $ / shares shares	Apr. 30, 2021 USD ($) $ / shares shares	Oct. 31, 2021 USD ($) $ / shares shares
Number of Shares
Balance Outstanding, October 31, 2021 (in shares)	992,050		992,050
Exercisable, October 31, 2021 (in shares)	928,457		928,457
Stock Incentive Plan and Stock Option Grants to Employees and Directors
Number of Shares
Balance Outstanding, April 30, 2021 (in shares)			1,214,473
Granted (in shares)			0
Exercised (in shares)			(216,752)
Forfeited (in shares)			(4,419)
Expired (in shares)			(1,252)
Balance Outstanding, October 31, 2021 (in shares)	992,050	1,214,473	992,050
Exercisable, October 31, 2021 (in shares)	928,457		928,457
Weighted Average Exercise Price
Balance Outstanding, April 30, 2021 (in dollars per share) | $ / shares			$ 6.24
Granted (in dollars per share) | $ / shares			0
Exercised (in dollars per share) | $ / shares			5.77
Forfeited (in dollars per share) | $ / shares			4.61
Expired (in dollars per share) | $ / shares			2.76
Balance Outstanding, October 31, 2021 (in dollars per share) | $ / shares	$ 6.61	$ 6.24	6.61
Exercisable, October 31, 2021 (in dollars per share) | $ / shares	$ 6.72		$ 6.72
Stock Option Activity, Additional Disclosures
Options outstanding, weighted average remaining contractual term	1 year 6 months 21 days	1 year 10 months 17 days
Options exercisable, weighted average remaining contractual term	1 year 6 months 3 days
Options outstanding, aggregate intrinsic value | $	$ 172,313	$ 204,719	$ 172,313
Options exercisable, aggregate intrinsic value | $	$ 161,584		$ 161,584

XML

Stockholders' Equity - Schedule of All Options and Exercisable Options (Details)	6 Months Ended
	Oct. 31, 2021 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding (in shares) | shares	992,050
Exercisable (in shares) | shares	928,457
$3.24 to $4.38
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum exercise price (in dollars per share)	$ 3.24
Maximum exercise price (in dollars per share)	4.38
Weighted average exercise price (in dollars per share)	$ 3.82
Outstanding (in shares) | shares	179,264
Weighted average exercise price (in dollars per share)	$ 3.81
Weighted average remaining life in years	9 months 10 days
Exercisable (in shares) | shares	166,597
$4.50 to $5.20
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum exercise price (in dollars per share)	$ 4.50
Maximum exercise price (in dollars per share)	5.20
Weighted average exercise price (in dollars per share)	$ 4.94
Outstanding (in shares) | shares	153,944
Weighted average exercise price (in dollars per share)	$ 5.00
Weighted average remaining life in years	1 year 11 months 26 days
Exercisable (in shares) | shares	111,019
$5.95 to $6.28
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum exercise price (in dollars per share)	$ 5.95
Maximum exercise price (in dollars per share)	6.28
Weighted average exercise price (in dollars per share)	$ 5.95
Outstanding (in shares) | shares	28,000
Weighted average exercise price (in dollars per share)	$ 5.95
Weighted average remaining life in years	9 months 21 days
Exercisable (in shares) | shares	28,000
$7.17 to $7.55
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum exercise price (in dollars per share)	$ 7.17
Maximum exercise price (in dollars per share)	7.55
Weighted average exercise price (in dollars per share)	$ 7.45
Outstanding (in shares) | shares	473,093
Weighted average exercise price (in dollars per share)	$ 7.46
Weighted average remaining life in years	1 year 9 months 25 days
Exercisable (in shares) | shares	465,092
$8.57 to $9.07
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum exercise price (in dollars per share)	$ 8.57
Maximum exercise price (in dollars per share)	9.07
Weighted average exercise price (in dollars per share)	$ 8.98
Outstanding (in shares) | shares	157,749
Weighted average exercise price (in dollars per share)	$ 8.98
Weighted average remaining life in years	1 year 2 months 4 days
Exercisable (in shares) | shares	157,749

XML

Revenue - Schedule of Disaggregated Revenue (Details) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Disaggregation of Revenue [Line Items]
Revenue	$ 18,940,211	$ 16,971,045	$ 38,371,206	$ 32,136,607
Tuition
Disaggregation of Revenue [Line Items]
Revenue	16,632,114	14,974,682	33,753,794	28,341,990
Course fees
Disaggregation of Revenue [Line Items]
Revenue	1,982,771	1,786,364	3,986,111	3,386,057
Book fees
Disaggregation of Revenue [Line Items]
Revenue	15,018	46,037	42,777	85,175
Exam fees
Disaggregation of Revenue [Line Items]
Revenue	194,371	78,900	390,413	149,555
Service fees
Disaggregation of Revenue [Line Items]
Revenue	$ 115,937	$ 85,062	$ 198,111	$ 173,830

XML

Revenue - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020	Apr. 30, 2021
Disaggregation of Revenue [Line Items]
Deferred revenue	$ 10,191,241		$ 10,191,241		$ 6,825,014
Recognition of deferred revenue			$ 5,407,735
Revenue Benchmark | Non-US | Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenues from students outside the United States	1.00%	1.00%	1.00%	1.00%

XML

Leases - Narrative (Details)	3 Months Ended		6 Months Ended
	Oct. 31, 2021 USD ($) ft²	Oct. 31, 2020 USD ($)	Oct. 31, 2021 USD ($) ft²	Oct. 31, 2020 USD ($)
Lessee, Lease, Description [Line Items]
Amount of office and classroom space leased (in square feet) | ft²	174,528		174,528
Lease extension term	5 years		5 years
Total future minimum lease payments (as a percent)	95.00%		95.00%
Incremental borrowing rate (as a percent)	12.00%		12.00%
Amortization of tenant improvement allowances	$ 152,499	$ 302,887	$ 0	$ 0
Lease expense	916,435	$ 664,415	1,853,172	$ 1,061,653
Leases not yet commenced, liability	$ 3,700,000		$ 3,700,000
Minimum
Lessee, Lease, Description [Line Items]
Lease term	7 years		7 years
Maximum
Lessee, Lease, Description [Line Items]
Lease term	10 years		10 years

XML

Leases - Schedule of Right-of-Use Assets (Details) - USD ($)	Oct. 31, 2021	Apr. 30, 2021
Leases [Abstract]
ROU assets - Operating facility leases	$ 15,958,721	$ 14,308,296
Less: accumulated reduction	(2,448,065)	(1,593,433)
Total ROU assets	$ 13,510,656	$ 12,714,863

XML

Leases - Schedule of Operating Lease Liabilities (Details) - USD ($)	Oct. 31, 2021	Apr. 30, 2021
Leases [Abstract]
Total lease liabilities	$ 22,436,658	$ 19,946,229
Reduction of lease liabilities	(2,558,744)	(1,617,600)
Present value of operating lease liabilities	$ 19,877,914	$ 18,328,629

XML

Leases - Future Minimum Payments Under Operating Leases (Details) - USD ($)	Oct. 31, 2021	Apr. 30, 2021
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
2022 (remaining)	$ 2,179,605
2023	4,142,637
2024	4,018,977
2025	3,802,959
2026	3,908,722
Thereafter	11,963,225
Total future minimum lease payments	30,016,125
Less: imputed interest	(10,138,211)
Present value of operating lease liabilities	$ 19,877,914	$ 18,328,629

XML

Leases - Schedule of Balance Sheet Information Related to Leases (Details) - USD ($)	Oct. 31, 2021	Apr. 30, 2021
Balance Sheet Classification
Operating lease obligations, current portion	$ 2,145,431	$ 2,029,821
Operating lease obligations, less current portion	17,732,483	16,298,808
Present value of operating lease liabilities	$ 19,877,914	$ 18,328,629

XML

Leases - Schedule of Other Information Related to Leases (Details)	Oct. 31, 2021
Other Information
Weighted average remaining lease term (in years)	7 years 3 months 14 days
Weighted average discount rate (percent)	12.00%

XML

Income Taxes (Details) $ in Thousands	Oct. 31, 2021 USD ($)
Income Tax Disclosure [Abstract]
Reserve for estimate of foreign income tax liability	$ 150

XML

Commitments and Contingencies (Details) - USD ($)				6 Months Ended	12 Months Ended
	Jul. 31, 2021	Jul. 21, 2021	Apr. 16, 2021	Oct. 31, 2021	Apr. 30, 2021	Dec. 31, 2020	Sep. 28, 2020	Aug. 31, 2020	Sep. 29, 2015	Feb. 11, 2013
Other Commitments [Line Items]
Estimate of potential loss										$ 2,200,000
Provisional certification, period			2 years
Return of unearned funds, no later than (in days)				45 days
Restricted cash				$ 1,433,397	$ 1,193,997
Customer Concentration Risk | Revenue Benchmark | Title IV Programs, Aspen University
Other Commitments [Line Items]
Concentration risk, percentage					44.72%
Customer Concentration Risk | Revenue Benchmark | Title IV Programs, United States University
Other Commitments [Line Items]
Concentration risk, percentage					33.81%
Collateral Pledged, Bank Letter of Credit
Other Commitments [Line Items]
Restricted cash				$ 9,872	$ 9,872	$ 369,473
Letter of Credit
Other Commitments [Line Items]
Letters of credit outstanding, amount							$ 255,708	$ 379,345
HEMG
Other Commitments [Line Items]
Amount of default judgment in litigation matter									$ 772,793
Proceeds from bankruptcy claims		$ 498,120
Writeoff of net receivable	$ 45,329